[go: up one dir, main page]

CN112203508A - Functional water - Google Patents

Functional water Download PDF

Info

Publication number
CN112203508A
CN112203508A CN202080003082.9A CN202080003082A CN112203508A CN 112203508 A CN112203508 A CN 112203508A CN 202080003082 A CN202080003082 A CN 202080003082A CN 112203508 A CN112203508 A CN 112203508A
Authority
CN
China
Prior art keywords
polyamine
salt
water
weight
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080003082.9A
Other languages
Chinese (zh)
Inventor
久保田徹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=70976393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN112203508(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CN112203508A publication Critical patent/CN112203508A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N3/00—Preservation of plants or parts thereof, e.g. inhibiting evaporation, improvement of the appearance of leaves or protection against physical influences such as UV radiation using chemical compositions; Grafting wax
    • A01N3/02—Keeping cut flowers fresh chemically
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/04—Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P17/00—Pest repellants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P21/00—Plant growth regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/02—Acaricides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/762—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B7/00—Preservation of fruit or vegetables; Chemical ripening of fruit or vegetables
    • A23B7/14—Preserving or ripening with chemicals not covered by group A23B7/08 or A23B7/10
    • A23B7/153—Preserving or ripening with chemicals not covered by group A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23F—NON-MECHANICAL REMOVAL OF METALLIC MATERIAL FROM SURFACE; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL; MULTI-STEP PROCESSES FOR SURFACE TREATMENT OF METALLIC MATERIAL INVOLVING AT LEAST ONE PROCESS PROVIDED FOR IN CLASS C23 AND AT LEAST ONE PROCESS COVERED BY SUBCLASS C21D OR C22F OR CLASS C25
    • C23F11/00—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent
    • C23F11/04—Inhibiting corrosion of metallic material by applying inhibitors to the surface in danger of corrosion or adding them to the corrosive agent in markedly acid liquids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/045—Organic compounds containing nitrogen as heteroatom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

The present invention relates to functional water containing a polyamine and/or a salt thereof as a functional component, wherein the total content of water, the polyamine, and the salt of the polyamine is 95 wt% or more. Preferably, the polyamine is at least 1 compound selected from the group consisting of a specific polyamine, a polymer having a structural unit derived from a specific cyclic amine, and a polymer having a structural unit derived from a specific unsaturated amine. The total content of the polyamine and/or the salt thereof is preferably 0.0001 to 10000 ppm by weight. The functional water has, for example, the following functions: maintaining food freshness, aging food, preventing corrosion, eliminating odor, regulating plant growth, prolonging life of cut flower, regulating cut flower blossom, expelling pests, repelling pests, improving constipation, reducing odor, lowering blood pressure, increasing body temperature, improving oral environment, inhibiting halitosis, and inhibiting body odor.

Description

Functional water
Technical Field
The invention relates to novel functional water with multiple functions.
Background
Water having various functions such as sterilization, cleaning, deodorization, health promotion, rust prevention, and plant growth promotion has been introduced into the market.
For example, patent document 1 describes a method for producing acidic electrolyzed water and a method for producing alkaline electrolyzed water, in which: an electrolytic cell and an electrolytic apparatus having the electrolytic cell, which improve the oxidation resistance of an anion exchange membrane. The acidic electrolyzed water is described as being used for sterilization, virus killing and deodorization, and the alkaline electrolyzed water is described as being used for deodorization, degreasing and particle removal.
Patent document 2 describes drinking water containing ultrafine gold particles, which is obtained by dispersing ultrafine gold particles in water in a floating manner. Patent document 2 describes that the functional water containing ultrafine gold particles can be directly drunk as health drinking water, and can be used as a main component or a subcomponent of a health improving agent, a cosmetic, a food preservative, a food freshness retaining agent, a pest repellent, an odor eliminating agent, or the like.
Patent document 3 describes antirust functional water having a slightly acidic or slightly alkaline property and a dissolved hydrogen/dissolved oxygen (molar concentration ratio) of at least 1. The rust-preventive functional water is described to have a function of preventing rust on the inner circumferential surface of a water supply pipe and to be suitably used as a drink, other household water, or domestic water.
Further, patent document 4 describes a plant cultivation method in which a plant is cultivated using cultivation water containing protium hydrogen. The cultivation water is described to control growth promotion, life extension, flowering, etc. of plants.
Documents of the prior art
Patent document
Patent document 1: japanese patent laid-open publication No. 2010-133007
Patent document 2: japanese patent laid-open No. 2008-214755
Patent document 3: japanese patent laid-open publication No. 2005-224696
Patent document 4: japanese patent laid-open No. 2012-55225
Disclosure of Invention
Technical problem to be solved by the invention
The water described in patent documents 1,3, and 4 is effective only for specific applications. Therefore, its use is limited. Further, gold, which is a functional component of patent document 2, is a noble metal and an expensive raw material. Therefore, the versatility is poor, and the continuous use is not facilitated in terms of cost. In addition, since all of the water described in patent documents 1 to 3 is produced using a special production apparatus, equipment investment is inevitable. In order to utilize the culture water described in patent document 4, special magnetic ceramic balls having strong reduction characteristics must be used.
As described above, it is difficult to say that the water described in patent documents 1 to 4 can be easily used by anyone, and is not widely used.
Therefore, an object of the present invention is to provide functional water that can be easily prepared and has excellent functions.
Another object of the present invention is to provide functional water that can be easily prepared and has various functions.
It is another object of the present invention to provide a material for the preparation of the functional water.
Another object of the present invention is to provide healthy drinking water that can be easily prepared and exerts excellent functions.
It is another object of the present invention to provide bottled water obtained by filling the healthy drinking water in a container.
Another object of the present invention is to provide a health improving agent that exerts an excellent function.
Means for solving the problems
The present inventors discovered that, when a fresh cabbage is pickled in water containing a certain polyamine and stored at room temperature for several years, the cabbage does not spoil at all and remains in the pickled state. Further research on this water has revealed that it has various functions: has no irritation to skin, is highly safe to drink, has bactericidal activity (antimicrobial activity), etc. Further, as a result of further research, it has been found that novel functional water having various functions can be easily obtained by mixing a polyamine and/or a salt thereof as a functional component with water in a given amount. The present invention has been completed based on these findings and through repeated studies.
That is, the present invention provides functional water containing a polyamine and/or a salt thereof as a functional component, wherein the total content of water, the polyamine, and the salt of the polyamine is 95 wt% or more.
The polyamine in the functional water is preferably at least 1 compound selected from the group consisting of a polyamine represented by the following formula (1), a polymer having a structural unit derived from a cyclic amine represented by the following formula (2), and a polymer having a structural unit derived from an unsaturated amine represented by the following formula (3),
[ chemical formula 1]
Figure BDA0002806611410000021
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 2]
Figure BDA0002806611410000031
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 3]
Figure BDA0002806611410000032
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
The total content of the polyamine and/or the salt thereof in the functional water is preferably 0.0001-10000 ppm by weight.
The functional water preferably has at least one of the following functions: maintaining freshness of food, aging food, preserving, deodorizing, cleaning, preventing rust, regulating plant growth, prolonging life of cut flower, regulating flower opening of cut flower, repelling pests, preventing and treating parasites, resisting microorganisms and viruses, improving constipation, reducing odor, lowering blood pressure, increasing body temperature, reducing urine sugar, reducing blood sugar, resisting cancer, relieving side effects of anticancer agent, resisting depression, schizophrenia, heart disease, asthma, rheumatism, Parkinson, gout, collagen disease, Alzheimer disease, blackening hair, canities, improving environment in oral cavity, inhibiting halitosis, inhibiting body odor, relieving pain, promoting healing of insect bite, promoting healing of wound, promoting healing of burn, relieving peripheral neuropathy and resisting inflammation. The functional water is more preferably, for example, a multifunctional water having two or more of the functions described above.
Further, the present invention provides a material for production of the functional water, the material for production containing a polyamine and/or a salt thereof.
Preferably, in the material for production, the total content of the polyamine and/or the salt thereof is more than 0.0001 ppm by weight and 100% by weight or less with respect to the entire material for production.
Further, the present invention provides a drinking water for health comprising a polyamine and/or a salt thereof as an active ingredient, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 4]
Figure BDA0002806611410000041
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 5]
Figure BDA0002806611410000042
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 6]
Figure BDA0002806611410000043
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
In the healthy drinking water, the total content of the polyamine and/or the salt thereof is preferably 0.0001 to 10000 ppm by weight.
Further, the present invention provides bottled water obtained by filling the container with the healthy drinking water.
In addition, the present invention provides a material for the production of said health drinking water, said material for the production containing a polyamine and/or a salt thereof.
In the material for production of health drinking water, the total content of the polyamine and/or the salt thereof may be more than 0.0001 ppm by weight and 100% by weight or less with respect to the entire material for production.
Further, the present invention provides a health improving agent comprising a polyamine and/or a salt thereof as an active ingredient, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 7]
Figure BDA0002806611410000051
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 8]
Figure BDA0002806611410000052
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 9]
Figure BDA0002806611410000053
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Are respectively independentAnd represents a hydrogen atom or a methyl group.
The total content of the polyamine and/or the salt thereof in the health improving agent is preferably 0.0001 to 10000 ppm by weight.
Effects of the invention
According to the present invention, there is provided: novel functional water and health drinking water which can be easily prepared and have excellent functions. The functional water of the present invention can exhibit various functions by containing a polyamine and/or a salt thereof as a functional component or an active component and setting the total content of water, the polyamine, and the salt of the polyamine to 95% by weight or more. The drinking water of the present invention can exhibit various health-improving effects by including a specific polyamine and/or a salt thereof as an active ingredient.
Examples of the functions include: maintaining freshness of food, aging food, preventing corrosion, removing odor, cleaning, preventing rust, regulating plant growth, prolonging life of cut flower, regulating cut flower blossom, repelling pests, resisting microorganism and virus, relieving constipation, reducing odor, lowering blood pressure, increasing body temperature, reducing urine sugar, reducing blood sugar, resisting cancer, relieving side effects of anticancer agent, resisting depression, schizophrenia, heart disease, asthma, rheumatism, Parkinson, gout, collagen disease, Alzheimer disease, blackening hair, canities, improving oral environment, inhibiting halitosis, inhibiting body odor, relieving pain, promoting healing of insect bite, promoting healing of wound, promoting healing of burn, relieving peripheral neuropathy and inflammation. The effects of the respective functions will be described in detail below.
[ antimicrobial function, antiviral function, cleaning function ]
The functional water of the present invention may have an antimicrobial function and an antiviral function. The functional water of the present invention was generally observed to have an effect on escherichia coli, staphylococcus aureus, Feline calicivirus (Feline calicivirus), but was not observed to have an effect on Aspergillus niger (Aspergillus niger). The exact mechanism is not clear, but it is presumed that the functional water of the present invention has a certain selective antimicrobial function. Since this aspergillus niger is a useful mold in the food field for manufacturing various enzyme preparations, it is suggested that it is particularly suitable for the hygienic management of the working environment in the food field for handling aspergillus niger. In addition, unlike sodium hypochlorite, the functional water of the present invention is not corrosive, does not irritate the skin, and is highly safe to be drinkable. In addition, unlike cleaning by chlorine-based chemicals, in the case where the functional water of the present invention is used for cleaning fresh foods such as vegetables and fruits, it is not necessary to wash with a large amount of water. Therefore, the flavor of the food itself is not easily impaired. For example, in the case of cleaning raw vegetables such as cut vegetables (particularly, scallion, green perilla leaf, mioga ginger, etc. for seasoning), since fragrance is not lost, the commercial value is not lowered. In addition, unlike conventional medicaments, the functional water of the present invention generally does not require rinsing. Therefore, water consumption in the food production process is suppressed, and the production cost is reduced.
[ Rust-preventive function ]
The functional water of the present invention can have an excellent rust prevention function. Therefore, maintenance efforts and costs for manufacturing metal food, equipment in food processing plants, kitchen equipment, cooking tools, and the like are significantly reduced. Further, in the case where the functional water of the present invention has the antimicrobial function, the antiviral function, and the cleaning function at the same time, it is natural to keep the operating environment of food manufacturing, equipment of food processing plants, and kitchens sanitary all the time by being used as water for food manufacturing on a daily basis. Therefore, it is not necessary to purchase or use various chemicals such as rust inhibitors and sterilizing agents separately according to the use. Further, safety to the operator is high, and burden on the environment is small.
[ function of maintaining freshness of food, function of aging food, preservative function, and parasite control function ]
The functional water of the present invention exerts a function of maintaining freshness of food by the antimicrobial function. Thus, freshness can generally be maintained without incurring spoilage of the food. For example, live fish or sliced fish may be put in the functional water of the present invention, vacuum-packed, and then packaged in cardboard and distributed to the market at room temperature to cold storage. Conventionally, in order to keep freshness of fish and shellfish and to circulate them, the following methods are used: live fish are transported while swimming by using a live fish cart having a live fish transporting tank (container) filled with seawater, or fish and shellfish are stored in a container filled with ice and transported by using a refrigerator car or a freezer car. However, the conventional conveying method increases the conveying cost and wastes a large space. When transporting the fish using a live fish car, a freezing car or a refrigerator car, it is necessary to prepare fresh seawater, ice, and an expensive live fish car for maintenance and management every time. Further, high costs are required for the disposal of contaminated seawater, ice, used containers, and the like after transportation. In this respect, the functional water of the present invention does not require transportation by a special live fish car or the like, a container filled with a large amount of ice, or the like, and does not require the disposal cost of contaminated seawater, ice, or used containers. Therefore, the transportation cost can be greatly reduced. In addition, the functional water of the present invention has a function of cooking food to increase delicious ingredients. For example, when the functional water of the present invention is used as a freshness retaining liquid and a preservative liquid and a maturing liquid, an unexpected synergistic effect can be obtained: not only reduces the circulation cost, but also is expected to obtain the cured rich flavor. Therefore, the added value of the food treated with the functional water of the present invention as a commodity is improved. Further, since a plurality of steps such as preservation, aging, etc. for keeping the freshness of food can be easily performed at one time, the operation efficiency is also excellent. In addition, the functional water of the invention can also play a role in preventing and treating parasites (anisakis). Conventionally, methods such as heat treatment (for example, heating at 60 ℃ for 1 minute) and freezing treatment (for example, freezing at-20 ℃ or lower for 24 hours or more) have been used for the prevention of anisakia, but such methods are not preferable for fresh fish and shellfish used for raw eating because they deteriorate the flavor. In this respect, since the functional water of the present invention exerts a parasite control function only by impregnating fresh fish and shellfish, the prevention of anisakia can be performed without spoiling the flavor. Further, since the fresh food can simultaneously have the above-mentioned functions of freshness maintenance, aging, preservation and the like, it is very useful as treated water (water for food production) for raw fish and shellfish.
[ plant growth regulating function ]
The functional water of the present invention may have a plant growth regulating function. The functional water of the present invention generally functions as: a function of promoting plant growth in a specific concentration range and inhibiting plant growth in a specific concentration range. The functional water of the present invention is expected to improve the yield and quality of plants (crops), and improve disease resistance. In addition, when the functional water of the present invention is used for hydroponics, if the functional water has the antimicrobial effect, the maintenance work is significantly reduced because the water quality of the cultivation water is expected to be maintained. This is expected to further improve the production efficiency.
[ function of prolonging the life of cut flowers and regulating flowering of cut flowers ]
The functional water of the present invention has the functions of prolonging the life of cut flowers and regulating the blooming of the cut flowers. Currently, in the flower industry, the following various attempts have been made to further improve freshness and storage stability of flowers: preparation of a distribution system (for example, storage by a temperature control device, transportation by a refrigerator car, or the like), use of various drugs such as various antibacterial agents and preservatives, and the like. However, all of these are accompanied by a substantial increase in cost. In this respect, the functional water of the present invention can easily extend the life of cut flowers and adjust the flowering of cut flowers at low cost without requiring special temperature control. Therefore, the functional water of the present invention is very useful in any stage of production place, market, retail store and consumer. Further, the storage and transportation costs of the cut flowers can be significantly reduced. The functional water of the present invention also has a function of promoting the development and flowering of a flower bud harvested in the bud stage of lily, for example. Therefore, the growth of flower buds and the unfolding speed of petals can be controlled, and the flowering day can be adjusted arbitrarily. That is, it can be controlled to flower simultaneously on days needed for a particular activity, ceremony, labrum, spring equinox, new year, etc. Waste can be minimized by flowering adjustment in this manner, and thus the profit margin of the producer can be increased. In the present specification, the term "cut flower" refers to a part which is cut from an appropriate part of a plant having a flower or a flower bud, and is mainly used for transportation and storage, and a part which is cut from a stem, a branch, a leaf, a flower, or a flower bud, and is mainly used for appreciation.
[ Pest-repelling and Pest-repelling function ]
The functional water of the present invention may have a repellent function against vermin. It is presumed that the functional water of the present invention has small water clusters and, when scattered, blocks the pores of pests such as mites, oilworms, scale insects, etc. to block air and suffocate them to death, thereby exerting a repellent function. Conventionally, pyrethroid insecticides, organophosphorus insecticides, carbamate insecticides, various synthetic miticides and the like have been used for controlling pests. However, these agents are not safe enough for humans. In this respect, even if the functional water of the present invention is prepared to be drinkable, it can exert a pest repellent function without causing resistance. In addition, in the case of being scattered on the bark, the polyamine remaining on the bark is expected to exert a repellent effect and prevent the insect pests from laying eggs on the bark.
[ deodorizing function ]
The functional water of the present invention can exhibit an excellent deodorizing function against any malodorous substance among ammonia, hydrogen sulfide and trimethylamine. For example, the functional water of the present invention can be filled in a spray container or the like, sprayed or dispersed in the air, a structure such as a building, or the like, to eliminate unpleasant odors such as tobacco odor, roast meat odor, human care odor, pet odor, and the like. Further, when the functional water of the present invention is used, tar stains and the like adhering to the wall surface can be removed by, for example, one wiping operation. And when the antimicrobial function, antiviral function, cleaning function, and the like are simultaneously provided, a synergistic effect of these can be expected. The functional water of the present invention can be applied to, for example, a medical site, a care site, a food industry, a takeout industry, an entertainment facility, or the like.
[ improving defecation, relieving fecal odor, lowering blood pressure, increasing body temperature, lowering urine glucose, lowering blood sugar, anticancer, relieving side effects of anticancer agent, anti-depression, anti-schizophrenia, anti-heart disease, anti-asthma, anti-rheumatism, anti-Parkinson, anti-gout, anti-collagen disease, anti-Alzheimer's disease, promoting blackening hair, anti-canities, improving the environment in oral cavity, inhibiting halitosis, inhibiting body odor, relieving pain, promoting healing of insect bites, promoting healing of wounds, promoting healing of burns, alleviating peripheral neuropathy and anti-inflammation ], etc. ]
The functional water of the present invention may have such functions that are beneficial to the health of humans and other animals (pets, livestock, etc.). Therefore, daily intake greatly contributes to improvement and maintenance of health conditions and to prolongation of health life. The exact mechanism is not clear, but it is presumed that the selective antimicrobial function possessed by the functional water of the present invention contributes to the balanced improvement of the intestinal environment of human beings and the like. Thus, it is considered that the defecation is improved, the foul smell of the stools is reduced, and the health state is maintained. In addition, when the functional water of the present invention is drunk, a phenomenon in which white hair is gradually changed into black hair may occur. In addition, when drinking the functional water of the present invention, concentration is increased, and the functional water is filled with dry strength and has improved pressure resistance, and therefore, it is expected that an antidepressant function can be achieved by daily intake.
The drinking water of the present invention has the same function as the functional water of the present invention. Daily health improvement can be greatly facilitated by daily drinking of the healthy drinking water of the present invention.
The healthy drinking water of the present invention can be used as bottled water (hereinafter, sometimes referred to as "the bottled water of the present invention") by filling the container with the healthy drinking water. The usability is further improved by making the bottled water, and the carrying, moving, storing and circulating are very convenient. In addition, when the various functions are provided at the same time, the functions can be used individually according to the scene as long as one bottle is provided. For example, the deodorant may be taken as refreshing drinking water for health promotion, may be filled in a spray container and sprayed as a deodorant, and may be sprayed on food for keeping freshness of the food. As described above, the functional water of the present invention is useful because it can be used for each function according to the purpose as long as there is one bottle.
In other aspects of the present invention, a functional water preparation material (hereinafter, sometimes also referred to as "the functional water preparation material of the present invention") and a health drinking water preparation material (hereinafter, sometimes also referred to as "the health drinking water preparation material of the present invention") are provided. The functional water preparation material and the health drinking water preparation material of the present invention can easily prepare a required amount of the functional water and the health drinking water of the present invention at the time of use by, for example, dilution with water or the like. Thus, compared with the case of storing or circulating as functional water, effective use of the storage space and the like can be realized without being too bulky.
In other aspects of the present invention, a health-improving agent (hereinafter, sometimes also referred to as "the health-improving agent of the present invention") is provided. By ingesting the health improving agent of the present invention, various functions (improvement of defecation, reduction of feces odor, reduction of blood pressure, increase of body temperature, reduction of urine glucose, reduction of blood glucose, anticancer, reduction of side effects of anticancer agents, antidepressant, anti-schizophrenia, anti-heart disease, anti-asthma, anti-rheumatism, anti-parkinson, anti-gout, anti-collagen disease, anti-alzheimer disease, promotion of hair blackening, anti-gray hair, improvement of the environment in the oral cavity, inhibition of halitosis, inhibition of body odor, analgesia, promotion of healing of insect bites, promotion of healing of wounds, promotion of healing of burns, alleviation of peripheral neuropathy, anti-inflammation, and the like) which are beneficial to the health of humans and other animals (pets, livestock, and the like) are expected to be exerted. Therefore, it can be taken daily for health improvement.
Drawings
FIG. 1 is a photograph showing the life prolonging function 1 (Rose) of the cut flower of test example 10.
FIG. 2 is a photograph showing the life prolonging function 2 (Eustoma grandiflorum: part 1) of the cut flower of test example 11.
FIG. 3 is a photograph showing the life prolonging function 3 (Eustoma grandiflorum: part 2) of the cut flower of test example 12.
FIG. 4 is a photograph showing flowering regulating function 1 (Eustoma grandiflorum) of the cut flowers of test example 13.
FIG. 5 is a photograph showing flowering-regulating function 2 (lily) of the cut flowers of test example 14.
FIG. 6 is a photograph showing the flowering-regulating function 3 (roses) of the cut flowers of test example 15.
FIG. 7 is a photograph showing the plant growth regulating function 1 (bean seedlings) of comparative example 4 and example 1 in test example 16.
FIG. 8 is a photograph showing the plant growth regulating function 1 (bean seedlings) of examples 4 to 8 in test example 16.
FIG. 9 is a photograph showing the plant growth regulating function 2 (germination of soybean) of test example 17.
FIG. 10 is a photograph showing the plant growth regulating function 3 (Ranunculus asiaticus) of test example 18.
FIG. 11 is a photograph of an affected part showing the anti-inflammatory function of test example 30 after applying the left thumb from a sprain and then applying example 1 to the affected part for 1 day.
FIG. 12 is a photograph showing the life prolonging function 4 (carnation) of the cut flower of test example 47.
Detailed Description
[ functional Water ]
The functional water of the present invention contains a polyamine and/or a salt thereof as a functional component, and the total content of water, the polyamine, and the salt of the polyamine is 95 wt% or more. In the present specification, "functional water" refers to water having a useful function that ordinary water (for example, pure water) does not have originally, and "functional water" is not a registered trademark.
The functional water of the present invention may contain components other than water, polyamine, and/or a salt thereof. In addition, the functional water of the present invention may contain only 1 type of each component, for example, polyamine and/or a salt thereof, or may contain two or more types of each component.
(Water)
Examples of water used in the functional water of the present invention include: natural water, tap water, ion-exchanged water, deionized water, distilled water, purified water, and the like.
The content of water in the functional water of the present invention is, for example, 80 wt% or more, preferably 85 wt% or more, more preferably 90 wt% or more, and further preferably 95 wt% or more (for example, 98 wt% or more, 99 wt% or more, 99.5 wt% or more, 99.95 wt% or more, 99.98 wt% or more) with respect to 100 wt% of the functional water of the present invention.
(polyamine and/or salt thereof)
The polyamine used in the functional water of the present invention is a compound having two or more amino groups in 1 molecule, and includes a polymer.
The amino group of the polyamine may constitute any one of a primary amine, a secondary amine, and a tertiary amine.
< polyamine >
Examples of the polyamine include polyamines represented by the following formula (1).
[ chemical formula 10]
Figure BDA0002806611410000111
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different.
The R is1、R2Each of the groups preferably represents a linear or branched alkylene group having 2 to 6 carbon atoms, and more preferably represents a linear or branched alkylene group having 3 to 5 carbon atoms.
The m preferably represents an integer of 0 to 500, more preferably an integer of 0 to 100, further preferably an integer of 0 to 50, and particularly preferably an integer of 0 to 10 (for example, 0 to 5).
Among the polyamines represented by the above formula (1), the polyamines in which m is 0 include, for example: ethylenediamine, 1, 2-diaminopropane, 1, 3-diaminopropane, 1, 4-diaminobutane (putrescine), 1, 5-diaminopentane, 1, 6-diaminohexane, 1, 7-diaminoheptane, 1, 8-diaminooctane, and the like.
Among the polyamines represented by the above formula (1), the polyamines having m of 1 or more include, for example: spermidine, spermine; polyvinylamines such as diethylenetriamine, triethylenetetramine, tetraethylenepentamine, pentaethylenehexamine, hexaethyleneheptamine, heptaethyleneoctamine, octaethylenenonamine, and nonaethylenedecamine; and polypropylene polyamines such as dipropylene triamine, triacrylate tetramine, tetrapropylene pentamine, pentapropylene hexamine, hexapropylene heptamine, heptapropylene octamine, octapropylene nonamine, and nonapropylene decamine.
As the polyamine represented by the formula (1), a commercially available product can be used. Examples of commercially available products are shown in table 1.
[ Table 1]
Name of composition Name of product Molecular weight Manufacturer(s)
Pentamethylene diamine Pentamethylene diamine 102.18 Tokyo Huacheng Industry Co.,Ltd.
Hexamethylene diamine Hexamethylene diamine 116.21 Tokyo Huacheng Industry Co.,Ltd.
Putrescine Putrescine 88.15 MP Biomedicals,Inc
Spermidine Spermidine, for molecular biology 145.25 FUJIFILM Wako Pure Chemical Co., Ltd
1, 3-propanediamine 1, 3-propanediamine, and a photoprimary 74.12 FUJIFILM Wako Pure Chemical Co., Ltd
In the polyamine represented by the formula (1), m represents an integer of 0 to 10 (particularly an integer of 0 to 5), preferably R1、R2Each independently represents a linear or branched alkylene group having 3 to 6 carbon atoms.
< Polymer having structural Unit derived from Cyclic amine >
Further, examples of the polyamine include a polymer having a structural unit derived from a cyclic amine represented by the following formula (2) (hereinafter, sometimes referred to as "polymer a"). The polymer a is obtained by ring-opening polymerization of a cyclic amine represented by the following formula (2).
[ chemical formula 11]
Figure BDA0002806611410000121
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group.
Examples of the cyclic amine represented by the formula (2) include: aziridine (ethyleneimine), 2-methylaziridine, 2-dimethylaziridine, 2, 3-dimethylaziridine, and the like. In the polymer a, examples of the homopolymer include: polyethyleneimine, poly (2-methylaziridine), poly (2, 2-dimethylaziridine), poly (2, 3-dimethylaziridine), and the like.
As the polymer A, a commercially available product can be used. Examples of commercially available products are shown in table 2.
[ Table 2]
Name of composition Name of product Molecular weight Manufacturer(s)
Polyethylene imine Polyethyleneimine (about 30% aqueous solution) 70000 (weight average molecular weight) Tokyo Huacheng Industry Co.,Ltd.
< Polymer having structural Unit derived from unsaturated amine >
Further, as the polyamine, for example, a polymer having a structural unit derived from an unsaturated amine represented by the following formula (3) (hereinafter, sometimes referred to as "polymer B") can be cited. The polymer B is obtained by polymerization of unsaturated groups of unsaturated amines represented by the following formula (3).
[ chemical formula 12]
Figure BDA0002806611410000131
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
Examples of the unsaturated amine represented by the formula (3) include: vinylamine, divinylamine, trivinylamine, allylamine, diallylamine, triallylamine, (2-methylallyl) amine, di (2-methylallyl) amine, tri (2-methylallyl) amine, crotylamine, dicrotonamine, tricrotonamine, 3-methyl-2-crotylamine, 3-crotylamine, and the like.
In the unsaturated amine represented by the formula (3), preferably n represents 0 or 1, p represents 1 or 2, R7、R8、R9A compound which is a hydrogen atom.
In the polymer B, examples of the homopolymer include: polyvinylamine (polyvinlyamine), polydivinylamine, polyallylamine, polydiallylamine, polytrienylamine, polymethacrylamide, polycrotonamine, poly (3-butenamine), and the like.
The weight average molecular weight of the polymer B is, for example, 100 to 200000, preferably 300 to 100000, and more preferably 500 to 50000.
Further, the polymer a and the polymer B may be a copolymer in addition to the homopolymer. The arrangement form of the copolymer can be any one of statistical, random, alternating and periodic copolymers, and the method for connecting polymer chains can be any one of block copolymers and graft copolymers.
When the polymer a is a copolymer, the copolymer may be a copolymer of two or more kinds of the cyclic amine represented by the formula (2), and when the polymer B is a copolymer, the copolymer may be a copolymer of two or more kinds of the unsaturated amine represented by the formula (3), or a copolymer of 1 or more kinds of the unsaturated amine represented by the formula (3) and another monomer copolymerizable with the unsaturated amine represented by the formula (3).
Examples of the other monomer copolymerizable with the unsaturated amine represented by the formula (3) include: sulfur dioxide, (meth) acrylamide, (meth) acrylate, (meth) acrylic acid, maleic acid, and the like.
When the polymer B is a copolymer, the proportion of the structural unit derived from the unsaturated amine represented by the formula (3) (including the structural unit having a substituent introduced on an amino group and the structural unit formed into a salt) to the whole copolymer is, for example, 20% by weight or more, preferably 40% by weight or more, more preferably 60% by weight or more, further preferably 80% by weight or more, and particularly preferably 90% by weight or more.
When the polymer B is a copolymer, the proportion of the structural unit (including the amino group-forming salt) having no substituent introduced on the amino group in the structural unit derived from the unsaturated amine represented by the formula (3) is, for example, 20% by weight or more, preferably 40% by weight or more, more preferably 60% by weight or more, further preferably 80% by weight or more, and particularly preferably 90% by weight or more, relative to the entire copolymer.
Further, the polyamine represented by the formula (1), the polymer a, and the polymer B may or may not have a substituent on an amino group in the molecule.
Examples of the substituent include: alkyl groups having 1 to 4 carbon atoms such as methyl and ethyl; acyl groups having 1 to 4 carbon atoms such as formyl, acetyl, propionyl and the like; an alkoxycarbonyl group having 1 to 4 carbon atoms in an alkoxy moiety such as a methoxycarbonyl group or an ethoxycarbonyl group; carbamoyl and the like. These substituents may be introduced at the monomer stage or after polymerization.
The polyamine used in the functional water of the present invention is preferably at least 1 compound selected from the group consisting of the polyamine represented by the formula (1), the polymer a, and the polymer B. Among these, the polyamine used in the functional water of the present invention is more preferably any one of the polymer a and/or the polymer B, and most preferably the polymer B, from the viewpoint of further excellent economy and further ease of starting.
As representative examples of the polymer having a structural unit derived from the unsaturated amine represented by the formula (3), i.e., the polymer B, there can be mentioned: homopolymers such as polyvinylamine, polydivinylamine, polyallylamine, polydiallylamine, polytrienylamine, poly (2-methylallyl) amine, polycrotonamine, poly (3-butenamine), diallylamine polymer, poly (N, N-dimethylallylamine), and poly (N-acetylallylamine); allylamine-diallylamine copolymers, allylamine-dimethylallylamine copolymers, partially methoxycarbonylated allylamine copolymers, partially carbamidated allylamine polymers, diallylamine-sulfur dioxide copolymers, methyldiallylamine-sulfur dioxide copolymers, diallylamine-acrylamide copolymers, allylamine-maleic acid copolymers, diallylamine-maleic acid copolymers, methyldiallylamine-maleic acid copolymers, partially formylated allylamine polymers, partially acetylated allylamine polymers, partially propionylated allylamine polymers, allylamine-N, N-dimethylallylamine copolymers, partially formylated diallylamine polymers, partially acetylated diallylamine polymers, partially propionylated diallylamine polymers, and the like.
As the polymer B, a commercially available product can be used. Examples of commercially available products are shown in table 3. The polyvinylamine can be produced, for example, by the method described in the specification of Japanese patent No. 3511626.
[ Table 3]
Name of composition Name of product Molecular weight Manufacturer(s)
Polyallylamine PAA-01 (15% aqueous solution) 1600 (weight average molecular weight) NITTOBO MEDICAL CO.K
Polyallylamine PAA-15C (15% aqueous solution) 15000 (weight average molecular weight) NITTOBO MEDICAL CO.K
Diallylamine polymers PAS-21 (15% aqueous solution) 5000 (weight average molecular weight) NITTOBO MEDICAL CO.K
Polyallylamine PAA-25 (10% aqueous solution) 25000 (weight average molecular weight) NITTOBO MEDICAL CO.K
Copolymer of allylamine and dimethylallylamine PAA-1112 (15% aqueous solution) 1000 (weight average molecular weight) NITTOBO MEDICAL CO.K
Copolymer of allylamine hydrochloride and diallylamine hydrochloride PAA-D11-HCL (40% aqueous solution) 100000 (weight average molecular weight) NITTOBO MEDICAL CO.K
The copolymerization ratio (molar ratio) of the copolymer is 1: 1.
As the polymer B, it is preferable that two or more different polymer chains are not crosslinked via a nitrogen atom derived from an amino group of the unsaturated amine.
The salt of the polyamine may be any of a salt with an acid and a quaternary ammonium salt. Examples of the acid include: inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, boric acid, and the like; 1-membered aliphatic carboxylic acids such as formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, caproic acid, caprylic acid, capric acid, and dodecanoic acid; 2-membered aliphatic carboxylic acids such as oxalic acid, malonic acid, succinic acid, glutaric acid, and adipic acid; hydroxycarboxylic acids such as glycolic acid, lactic acid, malic acid, tartaric acid, etc.; sulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid.
The total content of the polyamine and/or the salt thereof in the functional water of the present invention is, for example, 0.0001 to 10000 ppm by weight, more preferably 0.001 to 9000 ppm by weight, further preferably 0.01 to 8000 ppm by weight, particularly preferably 0.1 to 7000 ppm by weight, most preferably 0.5 to 6000 ppm by weight, and particularly preferably more than 0.8 ppm by weight (for example, more than 1 ppm by weight, preferably more than 2 ppm by weight, more preferably more than 3 ppm by weight, further preferably more than 4ppm by weight, and particularly preferably more than 5 ppm by weight), and 5000 ppm by weight or less (for example, 4000 ppm by weight or less, preferably 3000 ppm by weight or less, more preferably 2000 ppm by weight or less, further preferably 1500 ppm by weight or less, and particularly 1000 ppm by weight or less).
Hereinafter, preferred ranges of the total content of the polyamine and/or the salt thereof are shown for each function.
[ antimicrobial function, antiviral function, cleaning function, antirust function, function of keeping freshness of food, function of food aging, preservative function, pest extermination, pest repellency ]
The lower limit is preferably 1 ppm by weight, more preferably 5 ppm by weight, and still more preferably 7.5 ppm by weight, and the upper limit is preferably 5000 ppm by weight, more preferably 3000 ppm by weight, and still more preferably 2000 ppm by weight.
[ plant growth regulating function ]
Has the functions of inhibiting growth at a high concentration and promoting growth at a low concentration. The concentration at which the plant growth promoting function is exerted is, for example, 0.0001 to 750 ppm by weight, preferably 0.001 to 500 ppm by weight, more preferably 0.005 to 250 ppm by weight, and still more preferably 0.01 to 100ppm by weight (for example, 0.01 to 75 ppm by weight, preferably 0.01 to 50 ppm by weight, more preferably 0.001 to 25 ppm by weight, and still more preferably 0.01 to 10 ppm by weight). The concentration at which the growth inhibitory function is exerted is, for example, 750 to 10000 ppm by weight depending on the type of the target plant. In addition, when the function of promoting plant growth is exerted at an extremely low concentration, the growth-suppressing function may be exerted even if the concentration is, for example, 0.25 ppm by weight or more (preferably 0.3 ppm by weight, more preferably 0.5 ppm by weight or more, and still more preferably 0.75 ppm by weight or more).
[ function of prolonging the life of cut flowers and regulating flowering of cut flowers (flower buds) ]
The concentration at which the life prolonging effect is exhibited is, for example, 0.0001 to 500 ppm by weight, preferably 0.001 to 400 ppm by weight, and more preferably 0.005 to 300 ppm by weight. More preferably 0.01 to 250 ppm by weight. The concentration at which the flowering of cut flowers (including flower buds) is regulated is, for example, 0.0001 to 200 ppm by weight, preferably 0.001 to 150 ppm by weight, more preferably 0.005 to 100ppm by weight, and still more preferably 0.01 to 75 ppm by weight.
[ improving defecation, relieving fecal odor, lowering blood pressure, increasing body temperature, lowering urine glucose, lowering blood sugar, anticancer, relieving side effects of anticancer agent, anti-depression, anti-schizophrenia, anti-heart disease, anti-asthma, anti-rheumatism, anti-Parkinson, anti-gout, anti-collagen disease, anti-Alzheimer's disease, promoting blackening of hair, anti-canities, improving the environment in oral cavity, inhibiting halitosis, inhibiting body odor, relieving pain, promoting healing of insect bites, promoting healing of wounds, promoting healing of burns, alleviating peripheral neuropathy and anti-inflammation ]
The standard for the single daily dose of the polyamine and/or its salt is, for example, 0.01mg to 1500mg, preferably 0.1mg to 1000mg, more preferably 0.2mg to 500mg, and particularly preferably 0.5mg to 100 mg. For example, in the case of drinking functional water having a total content of polyamine and/or a salt thereof of 75 ppm by weight, when drinking an absolute amount of 30 mL/day, the polyamine and/or a salt thereof is taken at 2.25 mg/day.
[ other ingredients ]
The functional water of the present invention may contain various additives as other components as long as the effects of the present invention are not impaired. Examples of the other components include: the medicinal component, water-soluble dietary fiber, vitamins, minerals, fruit juice, perfume, thickening stabilizer, thickener, antiseptic, sweetener, surfactant, antioxidant, emulsifier, colorant, preservative, pH regulator, flavoring agent, sour agent, and quality stabilizer can be used alone or in combination of two or more.
From the viewpoint of maximizing the functions of the polyamine and/or the salt thereof, it is preferable that the functional water of the present invention does not substantially contain components other than water and the polyamine and the salt thereof. That is, the content of the other components is preferably less than 5% by weight, more preferably less than 3% by weight, still more preferably less than 1% by weight, and particularly preferably no mixing, based on 100% by weight of the functional water of the present invention. In the case where the other component is not substantially contained (less than 5% by weight), the effect of the polyamine and/or the salt thereof is more effectively exhibited because the other component in the aqueous solution does not interfere therewith.
The functional water of the present invention contains a polyamine and/or a salt thereof as a functional component, and the total content of water, the polyamine, and the salt of the polyamine is, for example, 95% by weight or more, preferably 98% by weight or more and 99% by weight or more, more preferably 99.5% by weight or more, further preferably 99.95% by weight or more, particularly preferably 99.98% by weight or more, and most preferably 100% by weight.
The pH of the functional water of the present invention is, for example, 5.0 to 9.0, preferably 5.8 to 8.6, more preferably 6.5 to 7.8, and particularly preferably 7.0 to 7.5. When the pH is within the range of 5.0 to 9.0, the beverage is free from extreme sour taste and bitter taste and is easy to drink. When the pH is within the range of 5.8 to 8.6, the pH value also satisfies the standard pH value of the water quality specified by the Japanese Water plant Law. Further, when the pH is neutral to weakly alkaline in the range of 7.0 to 7.5, it becomes easy to be absorbed into the body because it is more palatable and close to the pH of the body (about 7.4).
[ production of functional Water ]
The functional water of the present invention may be produced by a known method for producing a beverage or a known method for producing a liquid agent in the field of medicine, in addition to the step of containing the polyamine and/or the salt thereof as a functional component.
For example, the functional water of the present invention can be produced by the following method.
(step containing polyamine and/or salt thereof)
In the above step, the polyamine and/or a salt thereof is not particularly limited as long as the polyamine and/or a salt thereof can be added to raw material water (e.g., natural water, tap water, ion-exchanged water, deionized water, distilled water, purified water, or the like) and mixed and stirred to obtain uniform functional water.
As the polyamine and/or a salt thereof, a material for producing functional water of the present invention described later can be used. When the material for functional water preparation of the present invention is used, functional water can be more easily produced. For example, when the material for producing functional water of the present invention is a concentrated solution, a part of the raw material water may be diluted in advance to a desired ratio and added as an aqueous solution. In particular, when the concentration is low, if the dilution is performed stepwise (e.g., 10-fold dilution based on 10-fold dilution liquid, further 10-fold dilution), the concentration can be easily adjusted to the correct concentration, which is preferable. Further, for example, if 10mL of the material for functional water preparation of the present invention (for example, the amount of polyamine and/or salt thereof: 75 ppm by weight) is added after 10mL is drawn out from a container of a commercially available PET bottle containing 2L of mineral water, the functional water of the present invention having a total content of polyamine and/or salt thereof of 0.375 ppm by weight can be easily obtained. In the above step, other components (pH adjuster, perfume, etc.) may be added as necessary.
In addition to the above method, for example, the raw material water may be passed through a porous body containing the polyamine and/or the salt thereof (for example, a material obtained by supporting the polyamine and/or the salt thereof on the porous body), and the polyamine and/or the salt thereof may be continuously contained in the raw material water.
Examples of the material constituting the porous body include: mesoporous silica, silica gel, silica-alumina, ion exchange resin, diatomaceous earth, activated carbon, zeolite, acid clay, ceramics, cellulose, various resins, nonwoven fabric, woven fabric, or the like.
The mode of passing the raw material water through the porous body is not particularly limited, and examples thereof include the following methods: (1) a method of storing the porous body carrying the polyamine and/or the salt thereof in a water storage tank and supplying raw material water; or (2) a method in which the porous body is provided like a filter in a part of a water supply line for raw material water and water is continuously passed, and the like. Specific examples of (2) include conventional water purifier cartridges.
(other steps)
Other steps include: a heat sterilization step (for example, a method of heating at 60 ℃ for 10 minutes, at 85 ℃ for 30 minutes, or at 120 ℃ for 4 minutes), a cooling step, a filtration step, a filling step, a sealing step, an inspection step, a packaging step, and the like.
According to the method for producing functional water, the polyamine and/or the salt thereof can be contained in the raw water in a certain ratio, and the functional water can be easily and rapidly supplied.
[ Material for functional Water preparation ]
The functional water producing material of the present invention contains at least the above-mentioned polyamine and/or salt thereof as a functional component, and may further contain other components as exemplified above in addition to water.
The functional water preparing material of the present invention is a material that can prepare the functional water by, for example, dilution with water. The material for functional water preparation of the present invention can be in various liquid forms such as a solution, an emulsion, and a suspension, and can be solidified, semi-solidified, or encapsulated to be in various forms such as a gel, a capsule, a powder, a particle, and a granule.
The total content of the polyamine and/or the salt thereof is, for example, more than 0.0001 ppm by weight and 100% by weight or less with respect to the whole functional water preparation material of the present invention. The lower limit is preferably 0.1 ppm by weight, more preferably 1 ppm by weight, still more preferably 100ppm by weight, and particularly preferably 10000 ppm by weight (for example, 50000 ppm by weight). The upper limit is preferably 95% by weight, more preferably 90% by weight, still more preferably 80% by weight, and particularly preferably 70% by weight.
When the material for functional water production of the present invention contains components other than the polyamine and/or the salt thereof, the material can be produced in the same manner as in a known method for producing a beverage or food, except for the step of containing the polyamine and/or the salt thereof as a functional component.
[ health drinking water ]
The drinking water contains, as an active ingredient, at least 1 compound selected from the group consisting of polyamines represented by the formula (1), polymers having structural units derived from cyclic amines represented by the formula (2), and polymers having structural units derived from unsaturated amines represented by the formula (3), wherein m represents an integer of 0 to 1000, and R represents1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1Which may be the same or different, in formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group, in the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group. In the healthy drinking water of the present invention, the total content of water, the polyamine, and the salt of the polyamine is preferably 95% by weight or more.
The details of the polyamine represented by the formula (1), the polymer having a structural unit derived from the cyclic amine represented by the formula (2), and the polymer having a structural unit derived from the unsaturated amine represented by the formula (3) are the same as those described in the item of the functional water.
The content of water in the health drinking water of the present invention is, for example, 80 wt% or more, preferably 85 wt% or more, more preferably 90 wt% or more, and further preferably 95 wt% or more (for example, 98 wt% or more, 99 wt% or more, 99.5 wt% or more, 99.95 wt% or more, and 99.98 wt% or more) with respect to 100 wt% of the health drinking water of the present invention.
The total content of the polyamine and/or the salt thereof in the healthy drinking water of the present invention is, for example, 0.0001 to 10000 ppm by weight, more preferably 0.001 to 9000 ppm by weight, further preferably 0.01 to 8000 ppm by weight, particularly preferably 0.1 to 7000 ppm by weight, most preferably 0.5 to 6000 ppm by weight, and particularly preferably more than 0.8 ppm by weight (for example, more than 1 ppm by weight, preferably more than 2 ppm by weight, more preferably more than 3 ppm by weight, further preferably more than 4ppm by weight, and particularly preferably more than 5 ppm by weight), and 5000 ppm by weight or less (for example, 4000 ppm by weight or less, preferably 3000 ppm by weight or less, more preferably 2000 ppm by weight or less, further preferably 1500 ppm by weight or less, and particularly 1000 ppm by weight or less).
When the drinking water of the present invention is drunk, the standard for the single daily dose of the polyamine and/or the salt thereof is, for example, 0.01mg to 1500mg, preferably 0.1mg to 1000mg, more preferably 0.2mg to 500mg, and particularly preferably 0.5mg to 100 mg. For example, in the case of drinking functional water having a total content of polyamine and/or a salt thereof of 75 ppm by weight, when the absolute amount drunk per day is 30 mL/day, the polyamine and/or a salt thereof is to be taken at 2.25 mg/day.
The following functions are comprehensively exerted by daily drinking of the healthy drinking water of the present invention: improving constipation, relieving constipation odor, lowering blood pressure, increasing body temperature, reducing urine sugar, reducing blood glucose, resisting cancer, relieving side effects of anticancer agent, resisting depression, schizophrenia, heart disease, asthma, rheumatism, Parkinson, gout, collagen, Alzheimer, blackening hair, whitening hair, improving oral environment, inhibiting halitosis, inhibiting body odor, relieving pain, promoting healing of insect bite, promoting healing of wound, promoting healing of burn, relieving peripheral neuropathy and resisting inflammation. Therefore, it can contribute to health improvement of human beings and the like. The health-improving action exerted by the healthy drinking water of the present invention is particularly excellent, and examples thereof include: improving constipation, relieving constipation odor, lowering blood pressure, increasing body temperature, improving oral environment, inhibiting halitosis, and inhibiting body odor.
The healthy drinking water of the present invention can be used as "tap water" meeting the water quality standard of tap water and "water for food production" meeting the standard for water for food production by controlling the total content of the polyamine and/or the salt thereof. It can be said that water satisfying the respective standards is safe water that can be drunk by humans with ease.
In order to prepare the drinking water of the present invention so as to satisfy the standards for tap water and water for food production, the total content of the polyamine and/or the salt thereof in the drinking water of the present invention can be adjusted using the concentrations (10mg/L or less) of nitric nitrogen and nitrite nitrogen and the pH (5.8 to 8.6) as indices. In addition, in general, in order to adjust the total content of the polyamine and/or the salt thereof in the healthy drinking water of the present invention, water such as natural water, tap water, ion-exchanged water, deionized water, distilled water, and purified water may be used.
The drinking water of the present invention can be produced according to the method for producing functional water of the present invention.
[ bottled Water ]
The bottled water of the present invention means the healthy drinking water filled in the container. The filling container used for the bottled water of the present invention may be any type of container regardless of the form and material. Examples of such a filling container include: aluminum cans, steel cans, bottles, PET bottles, drums, sachets, paper containers, flasks, beakers, various capsule-type containers, or various laminated containers laminated with metal foil, plastic film, or the like.
The bottled water of the present invention can be produced by a known method for producing a beverage, the method comprising: a bottling step of filling the drinking water into bottles such as drinking water tanks, bottles, and PET bottles, and attaching labels or the like for recording necessary information to the respective bottles as necessary.
[ Material for producing healthy Drinking Water ]
The material for producing potable water according to the present invention contains at least the polyamine and/or the salt thereof, and may further contain, as necessary, other components as exemplified above in addition to water.
The material for healthy drinking water production of the present invention is a material that can produce the healthy drinking water by, for example, dilution with water. The material for producing drinking water for health purposes of the present invention may be in various liquid forms such as a solution, emulsion, and suspension, and may be solidified or semi-solidified into various forms such as powder, granule, and granule.
The total content of the polyamine and/or the salt thereof is, for example, more than 0.0001 ppm by weight and less than 100% by weight with respect to the whole of the material for producing healthy drinking water of the present invention. The lower limit is preferably 0.1 ppm by weight, more preferably 1 ppm by weight, still more preferably 100ppm by weight, and particularly preferably 10000 ppm by weight (for example, 50000 ppm by weight). The upper limit is preferably 95% by weight, more preferably 90% by weight, still more preferably 80% by weight, and particularly preferably 70% by weight.
When the material for producing healthy drinking water of the present invention contains components other than the polyamine and/or the salt thereof, the material can be produced in the same manner as a known beverage production method, except for including a step of containing the polyamine and/or the salt thereof as a functional component.
[ health-improving Agents ]
In another aspect of the present invention, there is provided a health-improving agent which is a health-improving agent containing a polyamine and/or a salt thereof as an active ingredient, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 13]
Figure BDA0002806611410000211
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 14]
Figure BDA0002806611410000212
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 15]
Figure BDA0002806611410000221
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
The details of the expressions (1) to (3) are the same as those described in the description of the functional water of the present invention.
In the health improver of the present invention, from the viewpoint of lower cost and ease of starting, it is more preferable that the polyamine is any one of a polymer having a structural unit derived from the cyclic amine represented by the formula (2) and/or a polymer having a structural unit derived from the unsaturated amine represented by the formula (3), and it is most preferable that the polyamine is a polymer having a structural unit derived from the unsaturated amine represented by the formula (3).
Further, the amino group in the molecule of any of the polyamine represented by the formula (1), the polymer having a structural unit derived from the cyclic amine represented by the formula (2), and the polymer having a structural unit derived from the unsaturated amine represented by the formula (3) may or may not have a substituent.
Examples of the substituent include: alkyl groups having 1 to 4 carbon atoms such as methyl and ethyl; acyl groups having 1 to 4 carbon atoms such as formyl, acetyl, propionyl and the like; an alkoxycarbonyl group having 1 to 4 carbon atoms in an alkoxy moiety such as a methoxycarbonyl group or an ethoxycarbonyl group; carbamoyl and the like. These substituents may be introduced at the monomer stage or after polymerization.
The salt of the polyamine may be any of a salt with an acid and a quaternary ammonium salt. Examples of the acid include: inorganic acids such as hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, boric acid, and the like; 1-membered aliphatic carboxylic acids such as formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, caproic acid, caprylic acid, capric acid, and dodecanoic acid; 2-membered aliphatic carboxylic acids such as oxalic acid, malonic acid, succinic acid, glutaric acid, and adipic acid; hydroxycarboxylic acids such as glycolic acid, lactic acid, malic acid, tartaric acid, etc.; sulfonic acids such as methanesulfonic acid and p-toluenesulfonic acid.
The total content of the polyamine and/or the salt thereof in the health improving agent of the present invention is, for example, 0.0001 to 10000 ppm by weight, more preferably 0.001 to 9000 ppm by weight, further preferably 0.01 to 8000 ppm by weight, particularly preferably 0.1 to 7000 ppm by weight, most preferably 0.5 to 6000 ppm by weight, and particularly preferably more than 0.8 ppm by weight (for example, more than 1 ppm by weight, preferably more than 2 ppm by weight, more preferably more than 3 ppm by weight, further preferably more than 4ppm by weight, and particularly preferably more than 5 ppm by weight), and 5000 ppm by weight or less (for example, 4000 ppm by weight or less, preferably 3000 ppm by weight or less, more preferably 2000 ppm by weight or less, further preferably 1500 ppm by weight or less, and particularly 1000 ppm by weight or less).
When the health improving agent of the present invention is drunk or administered, the standard for the single daily dose of the polyamine and/or the salt thereof is, for example, 0.01mg to 1500mg, preferably 0.1mg to 1000mg, more preferably 0.2mg to 500mg, and particularly preferably 0.5mg to 100 mg. For example, in the case of drinking a health improving agent having a total content of polyamine and/or a salt thereof of 75 weight ppm, when drinking an absolute amount of 30 mL/day, the polyamine and/or a salt thereof is to be taken at 2.25 mg/day.
The intake of the health improving agent of the present invention can exert various functions (improvement of defecation, reduction of stool odor, reduction of blood pressure, increase of body temperature, reduction of urine glucose, reduction of blood glucose, anticancer, reduction of side effects of anticancer agents, antidepression, anti-schizophrenia, anti-heart disease, anti-asthma, anti-rheumatism, anti-parkinson, anti-gout, anti-collagen disease, anti-alzheimer disease, hair blackening, anti-canities, improvement of the environment in the oral cavity, inhibition of halitosis, inhibition of body odor, analgesia, promotion of healing of insect bite, promotion of healing of wound, promotion of healing of burn, alleviation of peripheral neuropathy, anti-inflammation, and the like) that are beneficial to the health of human beings and the like. Therefore, it can be taken daily for health improvement of human beings and the like. The health-improving agent of the present invention exerts particularly excellent health-improving effects, and examples thereof include: improving constipation, relieving constipation odor, lowering blood pressure, increasing body temperature, improving oral environment, inhibiting halitosis, and inhibiting body odor.
[ other ingredients ]
The health improving agent of the present invention may contain various additives as long as the effects of the present invention are not impaired. The following additives may be used alone or in combination and mixed, and examples thereof include pharmaceutical ingredients, vitamins, minerals, fruit juice, water-soluble dietary fibers, flavors, thickening stabilizers, preservatives, sweeteners, surfactants, antioxidants, emulsifiers, coloring materials, spices, preservatives, pH adjusters, sour materials, and quality stabilizers.
The health improving agent of the present invention can be used as a beverage and food, and also as a medicine. For example, the health improving agent of the present invention comprehensively exerts the various beneficial functions, and therefore is very useful as a functional food (for example, a specific health food, a health supplement, a nutritional supplement).
The form and form of the health-improving agent of the present invention are not particularly limited as long as they are in a form or dosage form acceptable as a beverage, food or medicine. For example, when the health improving agent of the present invention is used in beverages and foods, it can be mixed with various commercially available beverages and foods and used, for example, liquid foods, various feeds, wheat flour products, ready-to-eat foods, agricultural processed products, processed marine products, processed livestock products, milk/dairy products, fats and oils, base seasonings, compound seasonings/foods, frozen foods, candies, various beverages, and the like. In addition, when the health improving agent of the present invention is a drug, it can be made into solid preparations such as powder, granule, tablet, capsule, etc.; liquid such as solution, syrup, suspension, emulsion, etc., suppository, ointment, etc.
The health-improving agent of the present invention can be produced by a method similar to a known production method using a raw material similar to a known beverage, food or drug, in addition to the step of containing an active ingredient which is at least 1 compound selected from the group consisting of the polyamine represented by the formula (1), the polymer having a structural unit derived from the cyclic amine represented by the formula (2) and the polymer having a structural unit derived from the unsaturated amine represented by the formula (3).
[ examples ]
The present invention will be described more specifically with reference to the following examples, but the present invention is not limited to these examples.
Examples 1 to 21 and comparative examples 1 to 4
Using the components listed in the table, test solutions of examples and comparative examples were prepared according to the formulations described in the table. The following evaluations were carried out using the respective test solutions shown in table 1.
[ Table 4]
Figure BDA0002806611410000241
[ test example 1: antimicrobial function (1)
After the test bacterial solutions (escherichia coli, staphylococcus aureus, aspergillus niger) were seeded in examples 1 to 8 and comparative examples 1 to 3 (above, detection materials), the number of viable bacteria in each test solution was measured after 24 hours.
The test conditions were as follows. The results are shown in tables 5 to 7.
(test bacterial solution)
Test bacterium 1: escherichia coli (Escherichia coli NBRC 3972)
Pre-culturing: ordinary agar medium [ Rongyan chemical Co., Ltd ], 35 ℃. + -. 1 ℃, 18-24 hours of bacterial liquid preparation solution: purified water
The number of bacteria is: 107 to 108/mL
Test bacterium 2: staphylococcus aureus (Staphylococcus aureus subsp. Aureus NBRC 12732)
Pre-culturing: common agar culture medium, at 35 +/-1 ℃ for 18-24 hours
Preparing a solution from a bacterial liquid: physiological saline
The number of bacteria is: 107 to 108/mL
Test bacterium 3: aspergillus niger (Aspergillus niger NBRC 105649)
Pre-culturing: potato dextrose agar medium (Difco) at 25 +/-1 ℃ for 7-10 days
Preparing a solution from a bacterial liquid: 0.005% dioctyl sodium sulfosuccinate solution
The number of bacteria is: 107 to 108/mL
(test solution)
0.1mL of test bacterial solution was inoculated into 10mL of each test material.
(storage Condition)
24 hours (Room temperature)
(viable cell count measurement)
Escherichia coli, staphylococcus aureus: SCDLP agar Medium [ Japanese pharmaceutical Co., Ltd ], dilution mixing plate culture method, 35. + -. 1 ℃ for 2 days
Aspergillus niger: GPLP agar Medium [ Japanese pharmaceutical Co., Ltd ], dilution mixing plate culture method, 25. + -. 1 ℃ for 7 days
[ Table 5]
Figure BDA0002806611410000251
[ Table 6]
Figure BDA0002806611410000261
[ Table 7]
Figure BDA0002806611410000262
Examples 1 to 5 and 8 showed the effect of sterilizing Escherichia coli and Staphylococcus aureus. In addition, examples 6 and 7 had a weak effect of sterilizing E.coli. On the other hand, in any of examples 1 to 8, no effect on Aspergillus niger was observed. Aspergillus niger is known as a fungus which is prevalent in the living environment and is useful in the food field for the manufacture of various enzyme preparations. Thus, examples 1 to 8 have selective antimicrobial functions. It is suggested that such selective antimicrobial function is particularly suitable for sanitary management of an operating environment in the field of food products in the brewing industry and the like.
[ test example 2: antimicrobial function (2)
Each sample (900. mu.L) was mixed with 100. mu.L of a bacterial solution (106 to 107 CFU/mL) in a sterilized plastic cup and allowed to stand. After 5, 30, and 60 minutes, 100. mu.L of each test solution was extracted and diluted 10-fold with 900. mu.L of physiological saline. The diluted solution was applied to a standard agar medium by a spiral spray, incubated at 35 ℃ for 48 hours, and the change in the number of bacteria in each test solution with the passage of time was observed. The results are shown in tables 8 to 10.
[ Table 8]
Figure BDA0002806611410000271
[ Table 9]
Figure BDA0002806611410000272
[ Table 10]
Figure BDA0002806611410000273
In examples 1 to 2 and comparative example 2, the number of bacteria decreased to the detection limit or less after 5 minutes. Therefore, in examples 1 to 2,2 kinds of lactic acid bacteria (Lactococcus lactis, Leuconostoc mesenteroides) and yeast (saccharomyces wakehamensis an yeast) showed bactericidal activity equivalent to 200 ppm by weight of sodium hypochlorite (comparative example 1).
[ test example 3: anti-virus function)
The effect on feline calicivirus was verified by spraying an appropriate amount of the test solution of example 1 on the surface of a medical surgical mask (nonwoven fabric). The results are shown in Table 11. Purified water was used as a control. As a result, an effect of reducing the number of feline calicivirus attached to the surface of the nonwoven fabric was observed.
[ Table 11]
Figure BDA0002806611410000281
The test solution of example 1 was observed to have an effect of reducing the number of feline calicivirus adhering to the surface of the nonwoven fabric. In the case of comparative example 1, no effect of reducing the number of feline caliciviruses was observed.
[ test example 4: antirust function ]
In a flat vessel having a diameter of about 5cm and a depth of 1cm, 2 to 3 clips (long diameter: 25mm) made of iron (nickel plating) were placed in each vessel, and then the test solutions of examples 1,3 to 5, 7, 13 to 18 and comparative example 1 were poured and completely immersed. The state of the clip after 7 days from the start of the test was visually observed, and the rust preventive function was evaluated according to the following criteria. The results are shown in Table 12.
< evaluation criteria for anticorrosive function >
O: no rusting was observed.
X: rusting was observed.
[ Table 12]
Figure BDA0002806611410000282
In comparative example 1, rust was observed, and in examples 1,3 to 5, 7, and 13 to 18, no rust was observed at all.
[ test example 5: freshness-retaining function of fish, aging function of fish
1000mL of each of the test solutions of example 1 and comparative example 1 was prepared, and 3 whole live horse mackerel were pickled in each of the test solutions for 10 minutes. Then, the horse mackerel taken out of each test liquid was wrapped with a food wrap and kept in a refrigerator for 3 days.
First, the odor of live horse mackerel before heat treatment prepared in example 1 and comparative example 1 was smelled, and whether or not the fishy odor as an index of freshness was prevented was evaluated by 3 japanese food experts based on the following evaluation criteria, based on the live horse mackerel prepared in comparative example 1.
< evaluation criteria for fishy smell >
And 5, dividing: in comparison with comparative example 1, no fishy smell was observed at all.
And 3, dividing: there was no fishy smell compared to comparative example 1.
1 minute: the fishy smell was the same as that in comparative example 1.
Subsequently, the live horse mackerel was cooked in a pan and eaten, and whether or not the meat quality was maintained was evaluated by 3 japanese cuisine experts according to the following evaluation criteria, based on the cooked horse mackerel obtained by heating the live horse mackerel prepared in comparative example 1.
< evaluation criteria for meat quality maintenance >
And 5, dividing: in comparison with comparative example 1, the fish meat was not dried at all, and the meat was in a very juicy state.
And 3, dividing: as compared with comparative example 1, the fish meat was not dried and the meat was juicy.
1 minute: the same degree of drying, compared to comparative example 1, resulted in less juicy meat.
The average score of the above 3-person scores was calculated, and the evaluation was excellent for 3.5 points or more, good for 3.5 points or less and 2.5 points or more (practically usable), and poor for 2.5 points or less, and the comprehensive evaluation was performed. The results are shown in Table 13.
[ Table 13]
Figure BDA0002806611410000291
It was revealed that the horse mackerel treated in example 1 had no fishy smell even after 3 days had elapsed, and was evaluated to have good meat quality and excellent freshness-retaining function. Furthermore, surprisingly, the horse mackerel treated in example 1 received the perception that the delicious taste was enhanced. It is presumed that the aging is promoted by the treatment in example 1, and the delicious taste is enhanced.
[ test example 6: freshness-retaining function of first-class meat, aging function of first-class meat
Each of the test solutions of example 1 and comparative example 1 was allowed to permeate commercially available Meat paper (Meat paper), and 100g of each of 3 pieces of the Meat of fei li beefsteak, produced in U.S. was wrapped with the Meat paper and kept in a refrigerator for 7 days. After 7 days, the meat of the american steak with feverfew processed in example 1 and comparative example 1 was cooked with a pan and eaten, and the meat obtained by heat-treating the meat of the american steak with feverfew prepared in comparative example 1 was evaluated by 3 western-style food experts on the basis of the following evaluation criteria with respect to discoloration and off-flavor, change in flavor, and whether or not the meat quality was maintained.
< evaluation criteria for discoloration, off-flavor, and flavor changes >
And 5, dividing: compared with comparative example 1, discoloration and off-flavor were completely absent, and the taste was as expected.
And 3, dividing: compared with comparative example 1, there was no discoloration, off-flavor, and taste as expected.
1 minute: in comparison with comparative example 1, there was discoloration and off-flavor, and the taste was not as expected.
< evaluation criteria for meat quality maintenance >
And 5, dividing: in comparison with comparative example 1, the beef steak meat was not dried at all, and the meat quality was in a very juicy state.
And 3, dividing: compared with comparative example 1, the beef steak meat was not dried, and the meat quality was in a juicy state.
1 minute: the same degree of drying, compared to comparative example 1, resulted in less juicy meat.
The average score of the above 3-person scores was calculated, and the evaluation was excellent for 3.5 points or more, good for 3.5 points or less and good for 2.5 points or more (practically usable), and poor for 2.5 points or less, and the comprehensive evaluation was performed. The results are shown in Table 14.
[ Table 14]
Figure BDA0002806611410000301
The meat of the american fei-flavor beefsteak treated in example 1 did not change color or smell even after 7 days had passed, had the desired flavor of the beefsteak, and had a juicy texture. These results show that the freshness-retaining function for high-quality meat is excellent. Furthermore, surprisingly, the American Feicili beef steak treated in example 1 received a fresh taste-enhanced perception. It is presumed that the treatment in example 1 promotes aging and enhances the delicious taste.
[ test example 7: freshness-retaining function of fruit
The freshness-retaining function of fruits in a water-preserved state in which the release of ethylene gas was suppressed was evaluated. Each 1 banana having no Sugar spot (Sugar spot) and skin was sealed with a wrap film for food, and then immersed in each test solution of example 1 and comparative example 1 for 14 days. Then, the banana peel was taken out from the test solution, and the appearance of the peel was visually observed and evaluated according to the following evaluation criteria.
< evaluation criteria of Banana pericarp >
O: the occupation area of brown spots in the banana peel is less than 30%.
And (delta): the occupation area of brown spots in the banana peel is more than 30% and less than 60%.
X: the occupation area of brown spots in the banana peel is more than 60%.
The appearance of example 1 was ≈ and the appearance of comparative example 1 was Δ. The results show that example 1 has a function of further maintaining the freshness of bananas under storage conditions in which the generation of ethylene gas is suppressed.
[ test example 8: anti-corrosive function 1
(1) Cabbage with cabbage
On day 11 of 2008. 4, a glass bottle containing about 200ml of the test solution of example 1 was prepared, and about 10 pieces of the sliced cabbage leaves cut into an appropriate size were immersed in the test solution, covered with a lid, and left to stand. By 1 month of 2019, the cabbage leaves are not rotten and smelly. The shape also substantially remains the original shape.
As a control, an experiment was carried out in the same manner except that tap water was used instead of the test solution of example 1, and as a result, the sample deteriorated from about 2008-4-20 days and became sludge-like and dissolved in water at the same year 6-15 days.
(2) Holland bean (pod pea)
On day 11 of 2008. 4.4, a glass bottle containing about 200ml of the test solution of example 1 was prepared, and 3 of the beans were immersed in the test solution, covered with a lid, and left to stand. By 2019, 1 month, the sweet broad pea is not rotten and has no foreign odor. The shape also substantially remains the original shape.
As a control, an experiment was carried out in the same manner except that tap water was used instead of the test solution of example 1, and as a result, the sample decayed from 2008 and about 4 and 20 days, and became sludge-like and decomposed to be water-soluble at the same year and 6 and 15 days.
(3) Section of fish (Limonitum maculatus (Longtooth group))
On day 11 of 2008. 4.4, a glass bottle containing about 200ml of the test solution of example 1 was prepared, and 1 piece of fish (blotchy grouper) was immersed in the test solution, covered with a lid, and left to stand. By 2019, 1 month, the fish slices are not rotten and have no off-flavor. The shape also substantially remains the original shape.
As a control, an experiment was carried out in the same manner except that tap water was used instead of the test solution of example 1, and as a result, the putrefaction started from about 2008-4-14 days, and the putrefaction became sludge-like and decomposed to be water-soluble at the same year, 4-20 days.
(4) Dead goldfish
On day 16/3/2013, a glass bottle containing about 1000ml of the test solution of example 1 was prepared, and a freshly dead goldfish (body length: about 17cm) was immersed in the test solution, covered with a lid, and left to stand. By 1 month of 2019, the goldfish is not rotten and smelly. The shape also substantially remains the original shape.
As a control, an experiment was carried out in the same manner except that tap water was used instead of the test solution of example 1, and as a result, the putrefaction started from about 3 to 20 days in 2013, and the putrefaction became sludge-like and decomposed to be water-soluble at 28 days in the same year, 4 and 28.
[ test example 9: deodorizing function)
The deodorizing function of example 1 was evaluated under the following test conditions. The test results are shown in table 15.
The test method comprises the following steps: test tube method
Test container: 5L SMART BAG PA
Amount of gas in the container: 3L
The gas measuring method comprises the following steps: detecting tube
Initial concentration of gas: ammonia 100ppm
Hydrogen sulfide 4ppm
Trimethylamine 28ppm
Test samples: a paper obtained by spraying and impregnating a commercially available paper with example 1 was used.
Comparison: blank test (paper obtained by performing the same operation without sample)
: water test (paper obtained by spraying water on commercially available paper and allowing it to penetrate)
Measuring time: 1. after 2 hours
[ Table 15]
Figure BDA0002806611410000321
It was revealed that example 1 had a deodorizing function for any one of ammonia, hydrogen sulfide and trimethylamine.
[ test example 10: function of prolonging life of cut flower 1 (Rose)
Each of the test solutions of examples 9 to 11 and comparative example 4 was prepared. Roses were used as cut flowers, which were contained in a container so that the cut of the roses was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The state of roses 4 days after the start of the test was observed by naked eyes. The test solutions were not exchanged during the test. The results are shown in FIG. 1.
Withering of the roses of comparative example 4 was observed, but no change was observed in the roses of examples 9 to 11. In the comparisons of examples 9 to 11, a life prolonging function was observed at all concentrations. Further, it is considered that the functional water of the present invention has an antimicrobial function, clogging the ducts of plants to inhibit the propagation of miscellaneous bacteria, and thus functions to contribute to the prolongation of the life of cut flowers.
[ test example 11: function of prolonging life of cut flower 2 (Eustoma grandiflorum: part 1) ]
Each of the test solutions of examples 16 to 18 was prepared. Eustoma grandiflorum was used as a cut flower, which was contained in a container such that the cut of eustoma grandiflorum was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The state of eustoma grandiflorum 15 days after the start of the test was observed by naked eyes. The test solutions were not exchanged during the test. The results are shown in FIG. 2.
The life prolonging effect was observed in all the examples.
[ test example 12: function of prolonging life of cut flower 3 (Eustoma grandiflorum: part 2) ]
Each of the test solutions of examples 1, 13 to 15 was prepared. Eustoma grandiflorum was used as a cut flower, which was contained in a container such that the cut of eustoma grandiflorum was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The condition of eustoma grandiflorum 11 days after the start of the test was observed by naked eyes. The test solutions were not exchanged during the test. The results of example 1 and example 15 are shown in fig. 3.
The life prolonging effect was observed in all the examples. The Eustoma russellianum soaked in example 1 kept a better flowering state than examples 13 to 14 (not shown) and 15.
[ test example 13: function of regulating flowering of cut flower 1 (Eustoma grandiflorum)
Each of the test solutions of examples 10 to 12 and comparative example 4 was prepared. Eustoma grandiflorum having buds and flowers was used as a cut flower, which was contained in a container so that the cut of eustoma grandiflorum was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The state of the flower buds and flowers 5 days after the start of the test was observed by naked eyes. The test solutions were not exchanged during the test. The results are shown in FIG. 4.
In the case of comparative example 4, the flower withered and the flower bud did not flower. On the other hand, the flower buds of examples 10 and 12 burst for 5 minutes, and the flower buds of example 11 burst for 8 minutes. In addition, the flowers of examples 10 to 12 did not wither.
[ test example 14: function of regulating flowering of cut flower 2 (Lily)
Each of the test solutions of examples 1,6 to 8 and comparative example 4 was prepared. The flower bud of lily was used as a cut flower, which was contained in a container so that the cut of lily was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The state of the flower buds of lily 12 days after the start of the test was observed visually. The test solutions were not exchanged during the test. The results are shown in FIG. 5.
The buds of the lilies of examples 1 and 7 are fully bloomed. Example 6 blooms for 5 minutes and example 8 blooms for 3 minutes. The flower buds of comparative example 4 did not flower.
[ test example 15: function of regulating flowering of cut flowers 3 (roses) ]
Each of the test solutions of examples 1,3 to 8 and comparative example 4 was prepared. Commercially available roses were used as cut flowers, which were contained in a container so that the cut of the roses was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The state of roses 10 days after the start of the test was observed by naked eyes. The test solutions were not exchanged during the test. The results are shown in FIG. 6.
The roses of comparative example 4 did not flower further relative to the start of the experiment. On the other hand, in examples 1 and 3 to 8, the flowering of the plants tended to be further advanced than at the beginning. Keeping in optimal flowering state after 10 days is example 1. For examples 4, 8, further flowering was achieved during the test period, with slight bending of the flower neck observed at the end of the test. Presumably the effect caused by the concentration of polyamine (probably due to the high concentration).
[ test example 16: plant growth regulating function 1 (Bean seedling)
Each of the test solutions of examples 1,3 to 8 and comparative example 4 was prepared. Commercially available bean seedlings were purchased, cut from a part of about 2cm or more of the root, and immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The rate of regeneration of soybean seedlings (regeneration from lateral buds) 9 days after the start of the test was visually observed. The test solutions were not exchanged during the test. The results are shown in FIGS. 7 and 8.
Examples 1,3 (not shown) and 4 to 8 are higher than comparative example 4 in the regeneration rate of soybean seedlings. In addition, the lateral buds of the bean seedlings of the examples grew more vigorously. In general, in the course of cultivating soybean seedlings for regeneration, it is necessary to change water every day in order to suppress the putrefaction of soybean, the generation of mold, and the generation of odor, but it is expected that the test water of the examples has an antimicrobial function, and therefore, the labor for changing water is reduced.
[ test example 17: plant growth regulating function 2 (germination of soybean) ]
Test solutions of example 12 and comparative example 4 were prepared. Gauze was placed on the bottom of the cylindrical container, and 30 water-soaked soybeans were sown. Then, each test solution was injected to such an extent that the soybeans in the container were covered. The mixture was left indoors at a temperature of 23 ℃ and a humidity of 40% for 7 days. After 7 days the germination was observed visually. The results are shown in FIG. 9.
The soybean soaked in example 12 had a higher germination rate than the soybean soaked in comparative example 4, and the sprouts grew more vigorously. It was shown that example 12 (amount of polyamine: 0.375 ppm by weight) had the function of promoting germination and rooting.
[ test example 18: plant growth regulating function 3 (Ranunculus asiaticus)
Test solutions of example 12 and comparative example 4 were prepared. Two ranunculus asiaticus are prepared and put into a seedling raising pot. Each test solution was spread to the extent that the soil became wet, and the soil was grown outdoors (on a balcony). The growth of ranunculus asiaticus was visually observed after 14 days. The results are shown in FIG. 10.
The growth of the ranunculus asiaticus seedlings with the example 12 (amount of polyamine: 0.375 ppm by weight) was significantly promoted compared to the ranunculus asiaticus seedlings with the comparative example 4. In particular, the surface area of the leaf and the height of the stem are grown to a size of about 1.5 times or more.
[ test example 19: function of expelling pests (Tetranychus urticae, oil bug and scale insect)
It is presumed that the vermin exterminating function of the functional water of the present invention may be a choking effect due to the small water clusters. Therefore, as a preliminary test, the difference in the evaporation time (evaporation rate) between the functional water and the purified water of the present invention was evaluated. This is evaluated based on the fact that the smaller the water cluster, the more easily water molecules fly out of the water surface, and the faster the water molecules evaporate.
Preparation test: verification that clusters of functional water are very small
100mL of each of the test solutions of comparative example 1 and example 1 was prepared. Each test solution was placed in a beaker, heated by an induction cooker under the following conditions, and the time until complete evaporation was measured by a stopwatch. At this time, the state of the liquid surface at boiling was visually observed.
Using a machine: NATIONAL induction cooker IH 3.0kW
The use state is as follows: reservoir 5 → medium strength
And (3) test results: comparative example 15 min 45 sec 73
Example 15 min 39 sec 98
As a result of the preliminary test, the test solution of example 1 evaporated more quickly than the test solution of comparative example 1. It is noted that, although the test liquid of example 1 was observed to be completely free from splashing, in comparative example 1, the number of water droplets flying near the boiling point was 100 or more, and therefore, it was necessary to mount a splash prevention frame and conduct a retest.
Main test 1: pest-repellent function (two-spotted spider mite)
The pest repellent function against tetranychus urticae was evaluated by the following procedure.
1. Tetranychus urticae (purchased from SUMIKA TECHNOSERVICE) was placed on the specimen
Figure BDA0002806611410000361
Upper (about 25 mm. times.75 mm).
2. The test solution of example 1 was filled in a commercially available spray container, and the test solution was sprayed on the tetranychus urticae on the specimen to the extent that the body of the mite became wet.
3. The time until the cessation of the activity was measured with a stopwatch by observing the activity of Tetranychus urticae (model name "DO. nature STV-451M", manufactured by KENKO TOKINA K.K.: 200 times) with a microscope.
The tetranychus urticae sprayed with the test liquid of experimental example 1 stops moving for about 30 seconds. The observation was then continued, but no activity was started again after the water droplets were dried. When observed under magnification, it was observed that fine droplets of the test liquid of example 1 were attached to the surface of tetranychus urticae. It is presumed from the results of the preliminary test that the functional water of the present invention has smaller water clusters than the purified water, and therefore, it is presumed that the pest extermination function is that the pores of the tetranychus urticae are clogged with the water droplets of the functional water of the present invention to suffocate the tetranychus urticae.
As a control, tap water was used in place of the test solution of example 1 to conduct the main test, and as a result, the activity of tetranychus urticae was not stopped.
Main test 2: pest repelling function (oil insect)
The pest extermination function against oil insects was evaluated by the following procedure.
The test solution of example 1 was filled into a commercially available spray container, and the test solution was sprayed to about 10 oil insects parasitizing roses. Survival was confirmed after 1 hour. As a result, all the oil insects stop moving and die. Then, even after the water droplets are dried, the activity is not started again.
In addition, as a control, tap water was sprayed instead of the test solution of example 1, and as a result, the oil insects were not killed at all.
Main test 3: pest repelling function (scale insect)
The test solution of example 1 was filled in a commercially available spray container, and the test solution was sprayed on several coccid parasitizing on plum. Survival was confirmed after 1 hour. As a result, all scale insects stop moving and die. Then, even after the water droplets are dried, the activity is not started again.
In addition, as a control, tap water was sprayed instead of the test solution of example 1, and as a result, only the scale insects were not killed.
[ test example 20: function for controlling parasites 1 (heterodera)
Several anisakid nematodes are extracted from the internal organs of several seriolas. The extracted anisakis were placed in a petri dish and the test solution of example 1 was injected. As a result, the movement of the anisakis was stopped at about 5 seconds. Then, even after the water droplets are dried, the activity is not started again.
It should be noted that, as a control, tap water was sprayed instead of the test solution of example 1, and as a result, only anisakis were not killed.
[ test example 21: function against parasites 2 (heterodera)
A slice (slice) of a seriolad was immersed in a vessel filled with the test solution of example 1. After 24 hours, it was confirmed that the anisakis flew out from the fillets (slices). It was found that the test solution of example 1 had an antimicrobial function, a food preservation function, a ripening function, and the like, and also had a parasite control function. It is suggested that the method is very useful for pretreatment of raw fish and shellfish for pricking.
[ test example 22: evaluation of safety 1
A single oral toxicity test was conducted using 5 male and female rats each, by an external testing facility, on rats of the test solution of example 1, with reference to the guidelines for drug toxicity testing. Example 1 was administered directly at a dose of 20 mL/kg. As a result, no abnormality was observed in the death case and the usual state during the observation period of 14 days. The weight change during the observation period was normal in all cases, and no abnormality was observed in the dissection. From the above results, it was confirmed that the test solution of example 1 used in an amount of 20mL/kg showed no toxicity to rats in the case of single administration.
[ test example 23: evaluation of safety 2
10mL of the test solution of example 1 was taken out of a commercially available PET bottle containing 2L of mineral water and contained in 10 mL. A water quality test was conducted on the obtained test material (concentration of polyamine: 0.375 ppm by weight), and it was confirmed that the test material was in accordance with the standards of "water suitable for drinking (water for food production)" according to the food sanitation act (water in accordance with the standard of item 26). It was confirmed that the test solution of example 1 can be safely drunk as water for food production or bottled water when diluted to an arbitrary ratio as a material for producing functional water of the present invention.
[ test example 24: defecation test (improving defecation function and reducing defecation odor function)
The test solution of example 1 was freely drunk by 5 healthy subjects A to E (3 males, 2 females, average age 56 years) in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The change in the amount of feces was recorded from day 1 to day 14 from the start of the test. The diet and exercise were normal except for taking the test solution of example 1. The state of defecation was evaluated in a self-answer manner based on the following criteria. The test results are shown in Table 16.
[ evaluation results ]
Very good: defecation (defecation amount is about 1.5 to 2 times)
O: defecation (defecation quantity common)
And (delta): defecation (less defecation quantity)
X: without defecation
[ Table 16]
Figure BDA0002806611410000382
Subjects B and D tended to have no defecation or fewer defecation times from the start of the test to day 4, but started around day 5 after the test liquid of example 1 was drunk, and observed defecation once a day although the amount of defecation was small, and continued to have a normal amount of defecation from day 6 after until the end of the test. On the other hand, the normal amount of defecation was observed from the beginning of the test in subjects a, C and E, but the amount of defecation tended to increase about 1.5 to 2 times after the 5 th day, and this increase continued until the end of the test. From the results, it is presumed that the intestinal environment of the subject was improved and the constipation was improved by the test solution of example 1. In addition, the subject reported the following perceptions: as defecation improves, the odor of the stool during defecation also decreases.
[ test example 25: function of lowering blood pressure
The test solution of example 1 was freely drunk by 5 healthy subjects A to E (3 males, 2 females, average age 56 years) in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The initial drinking start time of 1 day was 7 am. The blood pressure lowering function was evaluated by comparing the blood pressure levels at 1 day before the start of the test (9, 12, 20) and 14 days after drinking (9, 12, 20). The results are shown in Table 17.
[ Table 17]
Figure BDA0002806611410000381
A maximum reduction of 11mmHg in the highest blood pressure and a minimum reduction of 3mmHg at each time point after 14 days of drinking was observed in all subjects. No example of an increase in blood pressure was observed. The average value of the blood pressure after drinking for 14 days was reduced to around "normal blood pressure value (systolic blood pressure) 120 to 129" defined in "hypertension treatment guideline 2014" of the japan hypertension society, and the blood pressure lowering function of the functional water of the present invention was confirmed.
[ test example 26: lowering urine glucose function
The test solution of example 1 was freely drunk by 5 healthy subjects A to E (3 males, 2 females, average age 56 years) in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The initial 1 day drinking began at 7 am until 6 pm and was allowed to be freely ingested. Urine after 1 hour of diet was collected, and the color tone of the urine glucose testing drug (trade name "New uric acid Ga", manufactured by term MO corporation) soaked in urine for 1 second was compared with a color tone table, and each subject determined the concentration of glucose in urine by himself/herself. The results are shown in Table 18.
[ Table 18]
Figure BDA0002806611410000391
Only subject A detected a small amount of urine glucose at the beginning of the trial (100mg/dL), but after 14 days, little urine glucose was detected (50 mg/dL). The urine glucose test is an index for screening diabetes, and shows that the functional water of the present invention has a function of lowering urine glucose, and is useful for improving the health of a person having a high blood glucose level.
[ test example 27: function of raising body temperature (after drinking)
The test solution of example 1 was freely drunk by 5 healthy subjects A to E (3 males, 2 females, average age 56 years) in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The initial 1 day drinking began at 7 am until 6 pm and was allowed to be freely ingested. The body temperature 1 day before the start of the test (9, 12, 20) and 14 days after drinking (9, 12, 20) were compared to evaluate the body temperature elevating function. The results are shown in Table 19.
[ Table 19]
Figure BDA0002806611410000401
The body temperature after 14 days of drinking was confirmed to be increased by about 0.3 ℃ on average in each measurement point.
[ test example 28: function of raising body temperature (after bathing)
The body temperature raising function in the case where the functional water of the present invention is used as a bathing agent (external preparation) was tested. 5 healthy subjects A to E (3 males, 2 females, average age 56 years) were used as subjects. The test was carried out for a total of 2 days. On day 1 each subject first measured the body temperature before bathing. Then, after bathing in a bath room at 41 ℃ for 5 minutes, the body temperature was measured. On day 2, the body temperature before bathing was measured. Next, 10mL (amount of polyamine: 0.75mg) of the test solution of example 1 was added to a bath (41 ℃ C., 200L of hot water) and bathing was carried out for 5 minutes, followed by measuring the body temperature. The results are shown in Table 20.
[ Table 20]
Figure BDA0002806611410000402
It was confirmed that the body temperature was raised by about 0.5 ℃ when the test liquid of example 1 was added as a bathing agent, as compared with bathing without adding any substance. It was revealed that the body temperature raising function can be similarly obtained when the composition is used as a bathing agent (external preparation) as well as drinking.
[ test example 29: improving the environmental function in the oral cavity and suppressing the halitosis function
The oral cavity state when getting up in the next morning in the following cases was self-judged by the following evaluation criteria for 5 healthy subjects a to E (3 males, 2 females, average age 56 years). The results are shown in Table 21.
1. After brushing the teeth before bedtime, the test liquid of example 1 was sprayed to the inside of the oral cavity to wet the teeth
2. After brushing the teeth before sleeping, nothing is sprayed in the oral cavity
[ evaluation standards ]
O: not sticky at all in the mouth.
And (delta): slightly to slightly viscous in the mouth.
X: thick to sticky in the mouth.
[ Table 21]
Figure BDA0002806611410000411
It was found that if the test solution of example 1 was sprayed into the oral cavity before going to bed, the oral cavity was not sticky and a good oral environment was maintained the next morning. This is also presumed to suppress halitosis when getting up.
[ test example 30: anti-inflammatory function
Subject (Male, 70 years old)
The left thumb was sprained and felt very painful, and since no anti-inflammatory plaster was found, a commercially available adhesive plaster dipped in the test solution of example 1 was applied in a non-drying manner. The next day the phenomenon shown in fig. 11 occurs for the left thumb. Internal bleeding near the left thumb was severe, and when the plaster was removed, no internal bleeding occurred only at the site contacted with the test solution of example 1. It is assumed that either no internal bleeding occurred due to contact with the test solution prior to internal bleeding, or that the bleeding was healed at the same time. Since internal bleeding occurs in tissues, it can be reasonably assumed that it is not affected by substances attached to the outside. The test solution of example 1 is considered to stop bleeding at the affected part and exert an anti-inflammatory function.
[ test example 31: anticancer function)
Disease example 1:
test subject (female)
In administration of an anticancer agent for the treatment of breast cancer, the test solution of example 1 was initially drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Before that, the patient had recumbent disease for 3 days due to side effects, and after drinking, the side effects were reduced and almost disappeared. The product can be vigorously returned to the country when traveling out of sea on the next day of anticancer agent administration.
The disease example 2:
subject (female, 88 years old)
The onset of colon cancer at the age of 88 years old gradually progressed though slowly, and the progression of cancer was almost stopped when the test solution of example 1 was drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The people can live vigorously after 3 years of drinking.
The disease example 3:
test subject (Male)
Early bladder cancer was found and the physician suggested resection. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) simultaneously with ingestion of other health foods. Endoscopic surgery was performed 1 month later but no cancer was found, and a cancer-free state continued thereafter.
The symptoms are as follows:
test subject (Male)
Bladder cancer was found, and the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After 3 months of drinking, the tired body becomes relaxed immediately and becomes easier to work with as a result. After about 1 year of drinking, bladder cancer disappeared and continued drinking for the purpose of preventing metastasis (about 5 years).
The disease example 5:
test subject (female)
Diagnosed as advanced lung cancer, is declared the remaining 1 year life. The test solution of example 1 was drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) from 3 months after diagnosis. After 3 months of drinking, the skin became clean and vigorous. Cancer progression was stopped, physical strength was restored after 1 year of the declaration of remaining life, and overseas travel was performed with confidence for 10 days. In the current diagnosis, it is shown that the progression of cancer is halted and a large proportion of the cancers die.
The disease example 6:
test subject (female)
The breast was diagnosed as suspected breast cancer by mammography for health diagnosis. The test liquid of example 1 was started to be drunk in an absolute amount of 30m L/day (amount of polyamine: 2.25 mg/day). After 1 month from drinking, the results of the precision examination were diagnosed as no abnormality. The drinking is continued for about 4 years.
The disease example 7:
test subject (female)
In the stage of the development of bladder cancer, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Bladder cancer became small after 3 months. The drinking is continued for about 4 years.
The disease example 8:
test subject (female)
It was found that 18mm × 15mm × 13mm of breast cancer was not effective in the treatment with the anticancer agent, and was afflicted with side effects 4 months after the start of the treatment. Therefore, the doctor is notified that the cancer has decreased to 1/3 to 1/4 in an examination about 2 weeks after the test solution of example 1 is started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The physician then informs that surgery is not required, but that he wishes to do so. The dissected tumor died almost to leave only debris, no live tumor.
The disease example 9:
test subject (Male)
The test solution of example 1 was started to be drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) upon diagnosis of bladder cancer. It is said that in a state where progress is stopped in the diagnosis after 2 months, the drinking amount is increased to 40 mL/day (amount of polyamine: 3.0 mg/day), and the result shows that cancer is completely disappeared in the diagnosis after 2 months. The drinking is continued for about 4 years.
Disease example 10:
test subject (female)
The gastric cancer is found to be late, has been transferred to the liver, and is diagnosed as remaining 2-3 months of life. In a state of being treated with only an anticancer agent and being inoperable. The test solution of example 1 (30 mL of the test solution of example 1 was diluted to 70mL and administered) was drunk at an absolute amount of 30 mL/day (the amount of polyamine: 2.25 mg/day) from the next month, and as a result, gastric cancer diagnosed as inoperable in CT examination after 2 months became small, and the patient was able to live more vigorously despite the side effects of the anticancer agent. All cancer markers were reported to decline in value in the examination diagnosis after 4 months. The drinking is continued for about 3 years.
Disease example 11:
test subject (Male)
The test solution of example 1 was started to be drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) upon diagnosis of bladder cancer. The number of cancer markers was greatly reduced in the examination after 4 months, and the cancer was almost disappeared. Drinking is now continued (about 3 years) to prevent relapse.
Disease example 12:
test subject (female)
The test solution of example 1 was started to be drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) upon diagnosis of lung cancer. Complete disappearance of the cancer was shown in a close examination after 3 months.
The disease example 13:
test subject (Male)
The liver cancer is in a state of being changed from cirrhosis to a late stage liver cancer and being inoperable. Further, in a state where the cancer can enter the blood and be transferred to the whole body, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The progress of the cancer was confirmed to be stopped in the examination after about 3 months, and the progress was not made in the examination after about 4 months, and the administration of the anticancer agent was stopped and the treatment of hepatitis C was changed. People who have spent the rest of life announcements are now also energetic to live. Since recovery of physical strength was observed 10 months after drinking, surgery for removing 3 liver tumors was performed.
Disease example 14:
test subject (female)
Lung cancer recurred with cancer markers rising to 6.8. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After 2 months, the cancer marker dropped to 4.9. After 3 months it fell to 4.4. The cancer disappeared totally in the examination after 7 months.
Disease example 15:
subject (Male, 70 years old)
Diagnosed as bladder cancer, the kidneys were removed. About 10 metastases recur in the lungs after about 1 and a half years, in a state of accumulation of thoracic fluid. The test solution of example 1 was drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) from 1 month after the recurrence. In the examination about 4 months after the start of drinking, the number of metastatic cancers was reduced to 3, and all cancers were unchanged from the original size. The physician informs that the treatment with the anti-cancer agent should be stopped. In the diagnosis 6 months after the start of drinking, the thoracic fluid accumulated in the left lung was diagnosed to be reduced to 80%, and the remaining tumor was almost dead. Is basically solved. In addition, a state in which the thoracic fluid is completely disappeared and ameliorated is currently diagnosed.
Disease example 16:
subjects (female, 60 years old)
Diagnosed as advanced pancreatic cancer, is declared the remaining 1 year life. About 5 months after the start of diagnosis, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The progression of pancreatic cancer is said to stop in the examination diagnosis 5 months after the start of drinking. The weight of the product is increased by 6Kg compared with the weight of the product at the beginning of drinking, and the product is fully energetic after 1 year of the remaining life span. The smell of previously very smelly flatus almost disappears after drinking the liquid.
Disease example 17:
test subject (Male)
The test liquid of example 1 was started to be drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) to diagnose malignant brain tumor. After 3 months, the malignant brain tumor completely disappeared.
Disease example 18:
subjects (female, 50 years old)
The breast cancer was removed by surgery 3 years ago, and the test solution of example 1 was drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) starting from summer 1 year ago because of recurrence 1 year ago and transfer to the whole body such as bone, liver, lung, etc. The diagnostic result after 1 year from drinking gave a striking recovery, with a residual tumor count of only 2. Of course, anticancer agents, injections dedicated to breast cancer, and the like have been used in combination, and have been currently returned to the workplace.
Disease example 19:
test subject (Male, 65 years old)
The test solution of example 1 was drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) from 2 years ago in the case of onset of prostate cancer 3 years ago. Lean body weight increases and PSA values rise, becoming more energetic without treatment with anticancer agents.
Disease example 20:
test subject (Male, 75 years old)
The PSA value increased to 7, which was diagnosed as prostate cancer. The surgery needs to be performed with time. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After 3 months the PSA value dropped to 0.8 and became unnecessary for surgery, and the diagnosis of cancer was also cancelled.
Disease example 21:
test subject (Male, 65 years old)
Is diagnosed as liver cancer (stage 4). The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25m g/day). The examination confirmed the reduction of cancer 4 months after drinking.
Disease example 22:
test subject (Male, 60 years old generation)
Diagnosed as rectal cancer (stage 4 b). The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The CEA marker almost doubles 3 months after drinking. The elution of the labeled protein due to the collapse of cancer cells was judged to increase the value. As a result of continued drinking, the markers decreased and pain was also reduced at month 4.
Disease example 23:
test subject (Male, 60 years old)
It was also diagnosed as colorectal cancer (stage 4), and it was reported that surgery was not possible because there were 4 metastases. After about 1 month of diagnosis, treatment with an anticancer agent is started, and if the metastatic tumor is small, surgery will be performed. On the other hand, the test solution of example 1 was drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) from the time of diagnosis. After 2 months from the start of anticancer treatment (about 3 months from drinking), the examination results revealed that cancer was eliminated in 4 sites. The physician referred to as miracle performed the surgery 3 months after the start of the anticancer treatment. At this time, the body weight is increased by 10Kg, and the physical strength is maintained. The results of the surgery indicated a small amount of cancer remaining. Examination after 1 month of surgery indicated that residual cancer had also disappeared. The normal state is maintained at present.
Disease example 24:
subjects (female, 70 years old generation)
Pancreatic cancer, diagnosed as stage 4, is declared to remain 6 months of life. Before the anticancer agent treatment started in the next month, the test solution of example 1 was started to be drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). There were few side effects and anticancer agent treatment was completed. CT confirmation was performed at 5 months, and as a result, it was confirmed that the size of the cancer was shrinking. For about 1 year, the product is continuously drunk.
Disease example 25:
subjects (female, 65 years old)
Large bowel cancer of 6 cm in size was found with metastasis to both the lungs and uterus. The patient is subjected to a medical examination that is late at the time at a nearby hospital and transferred to a remote free medical hospital. The test solution of example 1 was drunk from this time in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Once the procedure was difficult to perform, it returned to a condition in which it was possible to perform the procedure. The resection of colon cancer, the removal of uterus, and the resection of diaphragm cancer were carried out. Then, return to the local place, go to the remote hospital once a week. Cancer is also not currently metastasized.
Disease example 26:
test subject (Male, 72 years old)
Malignant polyps were found and resected in esophagus, large intestine, stomach, but cancer markers were as high as 9.8 and the physician suspected that the cancer was metastasized and under treatment. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After 3 months from drinking, the marker decreased to 5.0. Now in a viewing state.
Disease example 27:
test subject (Male, 59 years old)
Since lung cancer is declared the remaining half-life. Shortly after declaration, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The progression of cancer stops after 5 months from drinking and after 6 months, the company is energetic. Has good appetite and can be used for golf.
Disease example 28:
subjects (female, 72 years old)
The lung cancer is diagnosed by examination. Before the anticancer agent was administered, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Examination was carried out after 2 months for drinking the anticancer agent, and as a result, the cancer disappeared and the administration of the anticancer agent was not required.
Disease example 29:
subject (Male, 70 years old)
Lung cancer, diagnosed as stage 4, is declared the remaining half-year life. Shortly after declaration, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The results of the diagnosis of cancer, which stopped progression and became smaller, were obtained in the examination 8 months after the start of drinking. It now becomes possible to go to golf and be recovering from health.
Disease example 30:
subjects (female, 70 years old generation)
The diagnosis was made of duodenal cancer, and it was decided to perform surgery 2 months later. Immediately after the diagnosis of cancer, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Surgery was performed 2 months after drinking. The doctor is the authority of the duodenum cancer in the private university hospital, and the removed part is sent to the bioscience institute in case of accident, and the result shows that the cancer is not the cancer.
Disease example 31:
subject (female, 78 years old)
Suffer from breast cancer for 10 years. The lesion is exposed to the surface of the breast in a circle of about 15cm, in a state of frequent bleeding. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The mass became small 1 month after drinking. Although the gum is weak, it becomes firm after drinking starts and tooth extraction is not required. In addition, the test liquid of example 1 was sprayed on the nose to make the state of the ears good, which suffered from ear abnormality for a long time.
The disease example 32:
test subject (female, 89 years old)
Suffering from dementia and having rectal cancer, receives the rest of the life declaration. According to the judgment of the doctor, the test solution of example 1 was applied to the focal area while drinking the test solution of example 1 in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The cancer exposed from the rectum to the inguinal region is reduced by application while the dementia is improved.
[ test example 32: anti-rheumatic disease function
Disease example 1:
test subject (Male, 59 years old)
Rheumatism is caused when the patient stays overseas, and the patient is difficult to get up in the morning. The test solution of example 1 was started to be drunk in an absolute amount of 50 mL/day (amount of polyamine: 3.75 mg/day), and the symptoms almost disappeared after about 3 months. After 2 years from drinking, the tea survived without seeing a doctor.
The disease example 2:
subjects (female, age 35)
The liquid was drunk at a time when the fingers were hard for 1 hour after waking up due to rheumatism and were enduring pain throughout the day (the absolute amount of the test liquid in example 1 was 50 mL/day, and the amount of polyamine was 3.75 mg/day). The next day of drinking begins with the loss of rigidity and pain. Then, when the liquid is used up and no longer consumed, some stiffness and pain recur the next day. When the drinking is restored in a hurry, the harshness and pain disappear the next day. After drinking, the tea is continued, and the symptoms are completely absent.
The disease example 3:
subjects (female, 70 years old)
The patient is difficult to walk and cannot get up in the morning due to the severe rheumatism. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). When drinking for 3 months, the morning getting up is easy and pain is relieved, thus reducing the steroid dose in the formulation from two to half a day, it is to be noted that the symptoms are still being reduced. It also becomes possible to walk, going from severe to moderate, and further gradually getting better to mild.
[ test example 33: anti-Parkinson function ]
Test subject (Male, 60 years old)
The test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) diagnosed as Parkinson's disease. After 3 months from drinking, it became possible to make the touch of the little finger and thumb of the hand that was not possible before. It is still drinking continuously (over about 8 months) today, giving better and better tactile sensation.
[ test example 34: analgesic function)
Test subject (Male, 65 years old)
It is severely painful and the cheeks are swollen due to tooth decay. The test liquid of example 1 was sprayed to the affected part every 10 minutes and after about 1 hour, toothache was cured and swelling was resolved. After which no medical examination by a doctor is received.
[ test example 35: anti-asthmatic function
Disease example 1:
test subject (female, 40 years old generation)
Suffering from asthma for a long period of time due to weak constitution, the test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) without asthma attack for 2 days. However, swelling of the tonsils, which is considered an improvement response, occurred, but then disappeared, and asthma also resolved.
The disease example 2:
subjects (female, 60 years old)
Patients with asthma who do not perspire. After the test liquid of example 1 started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) with the result that sweat concentrated on the face but the body did not sweat, the body became sweaty after 4 days and returned to the normal body constitution. In addition, asthma resolved.
[ test example 36: anti-white hair and hair blackening function
Subject (Male, 70 years old)
When the test solution of example 1 was drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) to promote daily health, the white hair roots were blackened, the hair roots were blackened, and the white hair was improved.
[ test example 37: anti-gout function)
Test subject (Male)
In the case of suffering from multiple gout attacks, the test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Thereafter, the uric acid level has been a value that may be attacked at any time, but is in a state of no attack for about 2 years.
[ test example 38: anti-collagen disease function
Test subject (Male, 72 years old)
Since the symptoms of fingertip cooling and skin whitening continued when the skin became cold due to collagen disease, the test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After about 2 months, the skin did not whiten.
[ test example 39: anti-Alzheimer's disease function
Disease example 1:
test subject (Male, 80 years old)
Patients with severe alzheimer's disease, have little ability to speak. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After about 2 months, it became a state in which the son returned and several conversations were performed when calling.
The disease example 2:
test subject (female, 90 years old generation)
In the case of dementia, the test solution of example 1 was initially drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and after about 3 months, the eyes without mental stress recovered the vitality and were clear. In addition, dementia symptoms are restored and conversation ability is restored. The test solution of example 1 was applied to the foot with beriberi to cure the beriberi immediately.
[ test example 40: anti-heart disease function)
Test animal (5 year old dog)
The natural heart disease causes the long-term passing of medicinal vitamins. The test solution of example 1 was allowed to drink in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After about 6 months, when going to hospital, the heart disease is cured.
[ test example 41: healing function of promoting wound ]
The test solution of example 1 was applied to an affected part of a patient who had inflammation of the gum after implant treatment and had not healed for 1 year, and the patient was instructed to use the solution by spraying the solution at home. As a result, the intractable inflammation of the gum was completely cured within 1 month. Similarly, when the test solution of example 1 was applied to other patients with severe gingival inflammation, the patients were completely cured within 1 month. The function of the test solution of example 1 to promote wound healing was confirmed. Note that these results are reported by the dentist.
[ test example 42: blood sugar lowering function, blood pressure lowering function, peripheral neuropathy alleviating function
Subjects (female, 70 years old)
The test solution of example 1 (absolute amount 20 mL/day, amount of polyamine: 1.5 mg/day) was started to be drunk when hypertension and diabetes were diagnosed. At the time of examination about 2 weeks after the start of drinking, the systolic blood pressure (maximum blood pressure) was reduced from about 150mmHg to around 135 mmHg. In addition, the blood glucose level also decreases. Analgesic drugs are taken all the time due to numbness and pain of limbs, but after 2 months, the numbness and pain of limbs are improved, and the administration of analgesic drugs can be stopped. Walking difficulty due to foot pain requires a crutch, but walking is possible without a crutch at present. The drinking is continued for about 6 months.
[ test example 43: antidepressant and anti-schizophrenia functions
Disease example 1:
test subject (Male)
Becoming mentally absent due to depression and continuing to live depressed at home, the test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After about 2 months, the life was returned to the original level for daily life and planning new career. It is presumed that, for some reason, neurotransmission is not smooth and is in a state of being unconscious, and the intake of the test solution of example 1 improves the state and becomes clear.
The disease example 2:
subjects (female, age 35)
Go to hospital for depression. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). 1 month after drinking, the tea gradually became bright and appeared smiling.
The disease example 3:
subject (female, 28 years old)
Depressive illness develops, always in a dull mood and without communication. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After about 2 months from the start of drinking, each person evaluated it to become bright. It becomes possible to make a good call with the person.
The symptoms are as follows:
test subject (Male, 30 years old generation)
In a state where reading is impossible due to schizophrenia. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The book is intended to be read about 1 month after the start of drinking and opened. The mother is full of hopes and is now continuing to drink.
[ test example 44: symptom relieving function for other diseases ]
Disease example 1:
test subject (Male)
There was a disease of growing mold from the tongue to the larynx because the resistance was weakened and the cells were in a state of being unable to overcome the mold, and the test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The fruit is completely cured after about 1 year of drinking. In addition, although the skin boundary of the subject was once easily ulcerated by ultraviolet rays due to leukoderma (a persistent disease in which skin is albinism), ulceration did not occur at all and the progress of albinism was stopped.
The disease example 2:
subject (female, 28 years old)
Patients in a state with ankylosing spondylitis and fibromyalgia and no treatment (strange disease of muscular ossification). The test solution of example 1 was started to be drunk (absolute amount of the test solution of example 1 was 20 mL/day, amount of polyamine: 1.5 mg/day). It became an almost completely cured state after about 2 months from the start of drinking.
The disease example 3:
subjects (female, 60 years old)
Suffering from symptoms (indeterminate complaint syndrome) with unknown reasons, such as migraine, edema of limbs, low body temperature, incapability of getting up on some days and the like, which are caused once every 3 days. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After 3 months from the start of drinking, most symptoms disappeared and were now energetic.
The symptoms are as follows:
subject (female, 25 years old)
The nasosinusitis is suffered from nasosinusitis, strong drugs are developed, but the nasosinusitis is not improved, and the drug administration is weakened because the drugs stronger than the nasosinusitis cannot be continuously used, but the symptoms are worsened, so the nasosinusitis is very troubled. The test of example 1 was dropped into the nose, and as a result, the pus was discharged to the mouth after several hours, and then the symptoms were improved. The symptoms will not worsen even if the drug is weakened, and the good state can be maintained.
The disease example 5:
subjects (female, 69 years old)
Suffering from spinal stenosis, the patient is also difficult to walk. The test solution of example 1 was drunk from this time in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Symptoms completely disappeared and recovered 2 months after drinking started.
The disease example 6:
subject (female, 36 years old)
The patient with cold sores was sprayed 5 times with the test solution of example 1 over 1 day, and the results were healed within 3 days. Generally, the medicine prescribed by a doctor needs 7 to 8 days.
The disease example 7:
subject (female, 25 years old)
Cataract had developed 2 years ago and progressed slowly, but when the test solution of example 1 was used as an eyedrop about 3 times a day, the head lamp dazzled the opposite car now also became not dazzling. Subjective symptoms are perceived to be improving.
The disease example 8:
subject (female, 36 years old)
About ten times of watery stool with unknown reasons occurred from 3 years ago, and the large intestine was examined, but the reasons were unknown. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and the result became soft stool twice a day.
The disease example 9:
test subject (Male, 39 years old)
Repeated diarrhea and constipation occur for 5 years, and symptoms of gastrointestinal drugs prescribed in hospitals are not changed even if the patients drink the drugs. The test solution of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and as a result, 3 weeks later, defecation became normal, and the number of times of defecation became 2 to 3 times a day.
Disease example 10:
test animal (5 year old dog)
Effusion occurs in the right and left salivary glands and swelling to a size smaller than that of the glass marble, so that the test solution of example 1 is drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and as a result, after 1 month, swelling in the left side is completely resolved and swelling in the right side is reduced to a slight degree.
Disease example 11:
test animal (dog age 3)
The skin is sensitive to redness, itchy and eczematous when the condition worsens. The test solution of example 1 was drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and all the cases were improved.
Disease example 12:
test subject (Male, 32 years old)
The test liquid of example 1 was sprayed to the site where atopic dermatitis developed, and as a result, the skin became clean after about 1 week.
The disease example 13:
test subject (3 female)
When the test liquid of example 1 was sprayed on the face every morning and evening, the skin became fine and pores became less noticeable. As a result, only foundation is needed to give the skin a transparent feeling.
Disease example 14:
subject (female, 59 years old)
When the test liquid of example 1 was sprayed on the hair, the roots stood up and became fluffy.
Disease example 15:
subject (female, 59 years old)
Subconjunctival hemorrhage occurred, and the test solution of example 1 was dropped, with the result that the eye was completely cured the next morning. Eye drops in a 2-week hospital are usually required.
Disease example 16:
test subject (Male, 60 years old)
Is diagnosed as ALS (amyotrophic lateral sclerosis). The test solution of example 1 was started to be drunk at an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day) after 2 months. After 4 months from the start of drinking, the disease hardly progresses. The future changes were observed.
Disease example 17:
subjects (female, 70 years old)
Over the years, hearing aids have suffered from sudden hearing impairment and started to be worn in the ear 5 years ago. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Shortly after drinking begins, it becomes clear of hearing impairment and the hearing aid can be removed. In addition, the hair becomes firmer and laxation is improved.
Disease example 18:
test subject (Male, 72 years old)
It is administered for hypertension. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Blood pressure begins to drop after drinking, and the blood pressure reducing agent is not taken at present. In addition, the value of diabetes became within the standard value. The facial sagging disappears and becomes firmer.
Disease example 19:
subjects (female, 75 years old)
In the following states: the patient feels vague and cannot talk with people in the morning and at night with fine sound because the patient feels inappetence and difficult to walk and generates heat when moving. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and as a result: the appetite is vigorous, the hospital food is eaten, the user can speak vigorously, the user does not generate heat when carrying out rehabilitation training, and the user can practice walking.
Disease example 20:
subjects (female, 68 years old)
Xerosis syndrome without saliva and dry mouth: (
Figure BDA0002806611410000541
syndrome) has become a lifelong condition and has abandoned hope. The test liquid of example 1 was initially drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day), and as a result, saliva began to gush out in some cases, which was promising.
Disease example 21:
test subject (Male, 40 years old)
In the state of hidden youth for 30 years since primary school. For a maximum of 4 days per week, part-time in a convenience store. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). After drinking for 2 months, the people have the intention of working in the IT enterprise, go out to take an examination and are qualified. It becomes possible to work for more than 8 hours in 1 day and socialize with people. No rebound exists in the last 1 year, and the life of the people is always taken as a social life.
Disease example 22:
subject (Male, 77 years old)
It has hearing impairment due to sequelae of cerebral infarction. The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). Hearing returned to normal after about 2 months from the beginning of drinking.
Disease example 23:
test subject (female, 50 years old generation)
Often subconjunctival hemorrhage, the ophthalmic drug is used for about 2 weeks. This time, the test solution of example 1 was dropped, and the cure was observed the next day.
[ test example 45: health improving function
Test subject (Male, 38 years old)
The test liquid of example 1 was started to be drunk in an absolute amount of 30 mL/day (amount of polyamine: 2.25 mg/day). The beginning of drinking is a character that tends to stay indoors. However, after about 2 months from the beginning of drinking, it becomes very fast to live through daily life, becoming actively buried in work. The drinking is continued for about 6 months. Usefulness as a health-improving agent was observed.
[ test example 46: evaluation of Long-term safety ]
Subject (Male, 70 years old)
The test liquid of example 1 was drunk from about 10 years ago (the absolute amount of example 1 was 30 mL/day, the amount of polyamine: 2.25 mg/day). As a result of the continuous daily consumption, there are no side-effect symptoms and the body shows a number of good phenomena: is easy to rapidly excrete toxic substances such as acetaldehyde and the like and can eliminate the old hair diseases of headache. Therefore, it was judged that there was no problem in long-term drinking.
[ test example 47: function of prolonging life of cut flower 4 (carnation)
Each of the test solutions of examples 19 to 21 and comparative example 4 was prepared. Carnation was used as a cut flower, which was contained in a container such that the cut of the stem of the carnation was immersed in each test solution. The temperature was 20. + -. 3 ℃ and the cells were left for about 10 hours per day under room light (fluorescent lamp) irradiation. The state of carnation 18 days after the start of the test was observed by naked eyes. The test solutions were not exchanged during the test. The results of examples 19 to 21 are shown in FIG. 12. (a) Example 19 is given as (b) example 20 and example 21 is given as (c). The left side is the photograph at the beginning of the test and the right side is the photograph after 18 days.
The carnation of comparative example 4 started to face down on day 10 and started to develop a noticeable color change on day 14. No change was observed in the carnations of examples 19, 20. A slight discoloration of the carnation of example 21 was observed on day 18. From the results of examples 19 to 21, it was found that the functional water of the present invention has a life prolonging effect on cut flowers of carnation.
[ test example 48: anti-corrosive function 2
4 glass bottles containing about 200ml of each of the test solutions of examples 19 to 21 and comparative example 4 were prepared, and beef was dipped in an appropriate amount of the test solution, covered with a lid, and left to stand for 18 days. In examples 19 to 21, beef was not spoiled at all. In the test of comparative example 4, putrefaction began on day 5 and was complete on day 7.
[ other prediction functions ]
The functional water of the present invention can be expected to synergistically exert other various functions (for example, other diseases, insect bite healing function, burn healing function, etc.) by the functions to promote health improvement. Further, since these compounds have various physiological functions, they are very useful as health-improving agents.
The details of the raw materials of the components used in the examples are shown in table 22.
[ Table 22]
Figure BDA0002806611410000561
The following notes variants of the invention.
Item [1] A food freshness retaining agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
Item [2] A food curing agent which comprises a polyamine and/or a salt thereof as a functional ingredient, and which has a total content of water, the polyamine and the salt of the polyamine of 95% by weight or more.
The preservative according to item [3], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The deodorizing agent according to item [4], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The cleaning agent according to item [5], which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The rust inhibitor according to item [6], which contains a polyamine and/or a salt thereof as a functional component, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
Item [7] A plant growth regulator comprising a polyamine and/or a salt thereof as a functional ingredient, and having a total content of water, the polyamine, and the salt of the polyamine of 95% by weight or more.
Item [8] A cut flower life prolonging agent which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
Item [9] A flowering regulator for cut flowers, which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, the polyamine, and the salt of the polyamine of 95% by weight or more.
Item [10] A pest repellent which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, the polyamine, and the salt of the polyamine of 95% by weight or more.
Item [11] A pest repellent which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, polyamine, and salt of polyamine of 95% by weight or more.
The parasite control agent according to item [12], which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, polyamine, salt of polyamine is 95% by weight or more.
An antimicrobial agent according to item [13], which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The item [14] an antiviral agent, which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The laxative improving agent according to item [15], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The above [16] A feces odor reducing agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The blood pressure lowering agent according to item [17], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The item [18] is a body temperature raising agent which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, the polyamine and the salt of the polyamine of 95% by weight or more.
Item [19] A urine sugar lowering agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The item [20] is a blood glucose lowering agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
The item [21] is an anticancer agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The item [22] is an anticancer agent-induced side effect reducing agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The above-mentioned antidepressant or schizophrenia inhibitor according to item [23], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
Item [24] an anti-asthma agent which comprises a polyamine and/or a salt thereof as a functional ingredient, and which has a total content of water, polyamine, and a salt of polyamine of 95% by weight or more.
The anti-rheumatic agent according to item [25], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The item [26] an antiparkinsonian agent which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, the polyamine, and the salt of the polyamine of 95% by weight or more.
The anti-gout agent according to item [27], which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
Item [28] an anti-collagen agent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
An anti-Alzheimer's disease agent according to item [29], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
The hair blackening accelerator according to item [30], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
An anti-graying agent according to item [31], which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
Item [32] an oral cavity environment-improving agent or halitosis inhibitor, which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, the polyamine, and the salt of the polyamine of 95% by weight or more.
The anti-cardiac agent according to item [33], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
Item [34] A body odor inhibitor which comprises a polyamine and/or a salt thereof as a functional ingredient, and which has a total content of water, the polyamine, and the salt of the polyamine of 95% by weight or more.
The analgesic agent according to item [35], which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
Item [36] an insect bite cure promoter which comprises a polyamine and/or a salt thereof as a functional ingredient, and the total content of water, the polyamine, and the salt of the polyamine is 95% by weight or more.
Item [37] A burn healing accelerator which comprises a polyamine and/or a salt thereof as a functional ingredient, and has a total content of water, polyamine and a salt of polyamine of 95% by weight or more.
Item [38] A peripheral neuropathy demulcent comprising a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
An anti-inflammatory agent according to item [39], which comprises a polyamine and/or a salt thereof as a functional ingredient, wherein the total content of water, the polyamine and the salt of the polyamine is 95% by weight or more.
Item [40] the agent according to any one of items [1] to [39], wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 16]
Figure BDA0002806611410000591
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 17]
Figure BDA0002806611410000592
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 18]
Figure BDA0002806611410000601
In the formula (3), n represents an integer of 0 to 2, and p isDenotes an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
Item [41] the agent according to item [40], wherein,
the total content of the polyamine and/or a salt thereof is 0.001 to 9000 ppm by weight (e.g., 0.01 to 8000 ppm by weight, preferably 0.1 to 7000 ppm by weight, more preferably 0.5 to 6000 ppm by weight, and particularly preferably more than 0.8 ppm by weight (e.g., more than 1 ppm by weight, preferably more than 2 ppm by weight, more preferably more than 3 ppm by weight, further preferably more than 4ppm by weight, and particularly preferably more than 5 ppm by weight), and 5000 ppm by weight or less (e.g., 4000 ppm by weight or less, preferably 3000 ppm by weight or less, more preferably 2000 ppm by weight or less, further preferably 1500 ppm by weight or less, and particularly preferably 1000 ppm by weight or less)).
The agent according to the item [42] to the item [15] to [39], wherein,
the polyamine and/or its salt is ingested in an amount of 0.01 to 1500mg (for example, 0.1 to 1000mg, preferably 0.2 to 500mg, more preferably 0.5 to 100mg) as a single daily dose.
Item [43] A health-improving agent which comprises a polyamine and/or a salt thereof as an active ingredient, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 19]
Figure BDA0002806611410000602
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 20]
Figure BDA0002806611410000611
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 21]
Figure BDA0002806611410000612
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group,
the total content of the polyamine and/or a salt thereof is 0.001 to 9000 ppm by weight (e.g., 0.01 to 8000 ppm by weight, preferably 0.1 to 7000 ppm by weight, more preferably 0.5 to 6000 ppm by weight, and particularly preferably more than 0.8 ppm by weight (e.g., more than 1 ppm by weight, preferably more than 2 ppm by weight, more preferably more than 3 ppm by weight, further preferably more than 4ppm by weight, and particularly preferably more than 5 ppm by weight), and 5000 ppm by weight or less (e.g., 4000 ppm by weight or less, preferably 3000 ppm by weight or less, more preferably 2000 ppm by weight or less, further preferably 1500 ppm by weight or less, and particularly preferably 1000 ppm by weight or less)).
Item [44] the health improving agent according to item [43], wherein,
the polyamine and/or its salt is ingested in an amount of 0.01 to 1500mg (for example, 0.1 to 1000mg, preferably 0.2 to 500mg, more preferably 0.5 to 100mg) as a single daily dose.
Industrial applicability
The functional water and health improving agent of the present invention can be easily prepared and have excellent functions. Since it has a variety of functions applicable to various uses, it is very useful in industry, public health, and human health.

Claims (13)

1. A functional water containing a polyamine and/or a salt thereof as a functional component, wherein the total content of water, the polyamine, and the salt of the polyamine is 95 wt% or more.
2. The functional water according to claim 1, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 1]
Figure FDA0002806611400000011
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 2]
Figure FDA0002806611400000012
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 3]
Figure FDA0002806611400000013
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
3. The functional water according to claim 1 or 2, wherein,
the total content of the polyamine and/or the salt thereof is 0.0001-10000 ppm by weight.
4. The functional water according to any one of claims 1 to 3, which has at least one of the following functions:
maintaining freshness of food, aging food, preserving, deodorizing, cleaning, preventing rust, regulating plant growth, prolonging life of cut flower, regulating flower opening of cut flower, repelling pests, preventing and treating parasites, resisting microorganisms and viruses, improving constipation, reducing odor, lowering blood pressure, increasing body temperature, reducing urine sugar, reducing blood sugar, resisting cancer, relieving side effects of anticancer agent, resisting depression, schizophrenia, heart disease, asthma, rheumatism, Parkinson, gout, collagen disease, Alzheimer disease, blackening hair, canities, improving environment in oral cavity, inhibiting halitosis, inhibiting body odor, relieving pain, promoting healing of insect bite, promoting healing of wound, promoting healing of burn, relieving peripheral neuropathy and resisting inflammation.
5. A material for production, which is the material for production of functional water according to any one of claims 1 to 4, wherein,
the preparation material contains polyamine and/or salt thereof.
6. The material for preparation according to claim 5, wherein,
the total content of the polyamine and/or the salt thereof is more than 0.0001 ppm by weight and less than 100% by weight relative to the whole of the material for preparation.
7. A drinking water for health, which contains a polyamine and/or a salt thereof as an effective ingredient, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 4]
Figure FDA0002806611400000021
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 5]
Figure FDA0002806611400000022
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 6]
Figure FDA0002806611400000031
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
8. The health drinking water according to claim 7, wherein,
the total content of the polyamine and/or the salt thereof is 0.0001-10000 ppm by weight.
9. A bottled water obtained by filling the container with the health drinking water according to claim 7 or 8.
10. A material for preparation of health drinking water according to claim 7 or 8, wherein,
the preparation material contains polyamine and/or salt thereof.
11. The preparatory material according to claim 10, wherein,
the total content of the polyamine and/or the salt thereof is more than 0.0001 ppm by weight and less than 100% by weight relative to the whole of the material for preparation.
12. A health improving agent comprising a polyamine and/or a salt thereof as an active ingredient, wherein,
the polyamine is at least 1 compound selected from polyamines represented by the following formula (1), polymers having structural units derived from cyclic amines represented by the following formula (2), and polymers having structural units derived from unsaturated amines represented by the following formula (3),
[ chemical formula 7]
Figure FDA0002806611400000032
In the formula (1), m represents an integer of 0 to 1000, R1、R2Each independently represents a linear or branched alkylene group having 2 to 8 carbon atoms, and when m is 2 or more, a plurality of R' s1May be the same or different from each other,
[ chemical formula 8]
Figure FDA0002806611400000033
In the formula (2), R3、R4、R5、R6Each independently represents a hydrogen atom or a methyl group,
[ chemical formula 9]
Figure FDA0002806611400000041
In the formula (3), n represents an integer of 0 to 2, p represents an integer of 1 to 3, R7、R8、R9Each independently represents a hydrogen atom or a methyl group.
13. The health-improving agent according to claim 12, wherein,
the total content of the polyamine and/or the salt thereof is 0.0001-10000 ppm by weight.
CN202080003082.9A 2019-01-28 2020-01-20 Functional water Pending CN112203508A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019012627 2019-01-28
JP2019021024A JP6708764B1 (en) 2019-01-28 2019-02-07 Functional water
JP2019-021024 2019-02-07
JP2019-012627 2019-06-07
PCT/JP2020/002642 WO2020158632A1 (en) 2019-01-28 2020-01-20 Functional water

Publications (1)

Publication Number Publication Date
CN112203508A true CN112203508A (en) 2021-01-08

Family

ID=70976393

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080003082.9A Pending CN112203508A (en) 2019-01-28 2020-01-20 Functional water

Country Status (5)

Country Link
US (1) US20210321653A1 (en)
EP (1) EP3918915A4 (en)
JP (2) JP6708764B1 (en)
CN (1) CN112203508A (en)
WO (1) WO2020158632A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113575622B (en) * 2021-08-27 2022-08-02 烟台固特丽生物科技股份有限公司 Preparation and application methods of banana peel-derived mite repellent
JPWO2023181844A1 (en) * 2022-03-25 2023-09-28
US11952290B2 (en) 2022-08-16 2024-04-09 Generosity Water, Inc. System and method for producing alkaline water having pH stability and increased mineral content
JP7489679B1 (en) 2023-10-23 2024-05-24 有限会社リベラル Carbon dioxide fixation device and battery

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06321787A (en) * 1993-05-12 1994-11-22 Sekisui Chem Co Ltd Carbohydrate absorption-inhibiting agent
US5679617A (en) * 1995-01-31 1997-10-21 Mitsubishi Chemical Corporation Agent and method for preserving freshness of cut flowers
US6093686A (en) * 1998-03-12 2000-07-25 Menicon Co., Ltd. Liquid for contact lenses
CN1509180A (en) * 2001-04-18 2004-06-30 ԭ���ø� Method for treating syndrome X with aliphatic polyamines
JP2005348626A (en) * 2004-06-08 2005-12-22 Takashi Omori Healthy drinking water and method for producing the same
CN100341409C (en) * 2002-12-19 2007-10-10 阿奇化工公司 Pypithione biocides enhanced by zinc metal ions and organic amines
CN101410367A (en) * 2005-08-10 2009-04-15 约翰·霍普金斯大学 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
CN102958366A (en) * 2010-07-01 2013-03-06 詹森药业有限公司 Antimicrobial combinations of pyrion compounds with polyethyleneimines
JP2016150334A (en) * 2015-02-19 2016-08-22 株式会社ネオス Emulsion breaking agent, and processing method of oil-containing aqueous solution

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS511626B2 (en) 1973-11-06 1976-01-19
JPS593724A (en) * 1982-06-29 1984-01-10 Matsushita Electric Ind Co Ltd Magnetic recording medium
US6423754B1 (en) * 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
JP2001026890A (en) * 1999-07-09 2001-01-30 Asahi Kagaku Kogyo Co Ltd Metal corrosion inhibitor, cleaning liquid composition containing the same, and cleaning method using the same
EP1214883B1 (en) * 1999-09-20 2003-11-26 Menicon Co., Ltd. Liquid preparation for contact lenses
JP4759781B2 (en) * 2000-01-28 2011-08-31 旭硝子株式会社 Monovalent cation selective permeable cation exchange membrane and method for producing the same
TWI237007B (en) 2001-02-27 2005-08-01 Phild Co Ltd Method and device for producing gold-containing high performance water
JP2003289795A (en) * 2002-04-05 2003-10-14 Tdk Corp Gas adsorbent and gas-adsorbing sheet
JP4385580B2 (en) * 2002-09-27 2009-12-16 チッソ株式会社 Bowel movement improver
JP4445767B2 (en) 2004-02-12 2010-04-07 ホシザキ電機株式会社 Method and apparatus for producing rust-proof functional water
JP4740874B2 (en) * 2004-11-18 2011-08-03 三井化学株式会社 LAMINATE CONTAINING MULTILAYER FILM BONDED BY HYDROGEN BOND, PROCESS FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING SELF-SUPPORTING THIN FILM OBTAINED FROM THE LAMINATE
JP2009507762A (en) * 2005-05-27 2009-02-26 ジョージア ステート ユニバーシティ リサーチ ファウンデーション、インコーポレイテッド Use of polyamines with antibiotics
US20080274929A1 (en) * 2007-05-01 2008-11-06 Whitekettle Wilson K Method for removing microbes from surfaces
JP5444592B2 (en) * 2007-05-31 2014-03-19 日東紡績株式会社 Rust preventive
CA2721478C (en) * 2008-04-18 2016-01-05 S.P.C.M. Sa Functionalized cationic polyamines and their use to reduce the ndma formation during the treatment of aqueous systems, and applications in the water treatment industry, includingwastewater and drinking water treatment processes
JP5417097B2 (en) 2008-11-06 2014-02-12 オルガノ株式会社 ELECTROLYTIC CELL, ELECTROLYTIC DEVICE, METHOD FOR PRODUCING ACIDIC ELECTROLYTIC WATER, AND METHOD FOR PRODUCING ALKALI ELECTROLYTIC WATER
JP5277997B2 (en) * 2009-01-29 2013-08-28 株式会社日立プラントテクノロジー Water purification method
JP5643581B2 (en) 2010-09-08 2014-12-17 株式会社Ｔａａｎｅ Plant cultivation method using water containing metal hydride
JP6422976B2 (en) * 2014-08-01 2018-11-14 国立研究開発法人産業技術総合研究所 Method for producing water containing permanganate ions
IL254696B1 (en) * 2015-04-10 2024-11-01 Basf Se Process for inhibiting the corrosion of metal surfaces
JP6966153B2 (en) * 2017-03-23 2021-11-10 住鉱潤滑剤株式会社 Anticorrosive composition

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06321787A (en) * 1993-05-12 1994-11-22 Sekisui Chem Co Ltd Carbohydrate absorption-inhibiting agent
US5679617A (en) * 1995-01-31 1997-10-21 Mitsubishi Chemical Corporation Agent and method for preserving freshness of cut flowers
US6093686A (en) * 1998-03-12 2000-07-25 Menicon Co., Ltd. Liquid for contact lenses
CN1509180A (en) * 2001-04-18 2004-06-30 ԭ���ø� Method for treating syndrome X with aliphatic polyamines
CN100341409C (en) * 2002-12-19 2007-10-10 阿奇化工公司 Pypithione biocides enhanced by zinc metal ions and organic amines
JP2005348626A (en) * 2004-06-08 2005-12-22 Takashi Omori Healthy drinking water and method for producing the same
CN101410367A (en) * 2005-08-10 2009-04-15 约翰·霍普金斯大学 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
CN102958366A (en) * 2010-07-01 2013-03-06 詹森药业有限公司 Antimicrobial combinations of pyrion compounds with polyethyleneimines
CN102958366B (en) * 2010-07-01 2015-02-11 詹森药业有限公司 Antimicrobial combinations of pyrion compounds with polyethyleneimines
JP2016150334A (en) * 2015-02-19 2016-08-22 株式会社ネオス Emulsion breaking agent, and processing method of oil-containing aqueous solution

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ELHAM DANAEE 等: "Effect of Different Concentration and Application Methods of Polyamines (Putrescine, Spermine, Spermidine) on Some Morphological, Physiological, and Enzymatic Characteristics and Vase Life of Rosa hybrida cv. ‘Dolce Vita’ Cut Flower", 《 JOURNAL OF ORNAMENTAL PLANTS》 *

Also Published As

Publication number Publication date
JPWO2020158632A1 (en) 2021-03-18
EP3918915A4 (en) 2022-05-11
JP6708764B1 (en) 2020-06-10
EP3918915A1 (en) 2021-12-08
US20210321653A1 (en) 2021-10-21
WO2020158632A1 (en) 2020-08-06
JP6945085B2 (en) 2021-10-06
JP2020116555A (en) 2020-08-06

Similar Documents

Publication Publication Date Title
CN112203508A (en) Functional water
JP5635676B2 (en) Sprouted cereal, method for producing the same, food containing the same, and BDNF production promoter
MXPA06009799A (en) Oral health care drink and method for reducing malodors.
JP2009051803A (en) Discovery of new method for extraction
CN104705358A (en) Sterilization disinfectant as well as preparation method and application thereof
CN108042578A (en) A kind of health care vaginal jellies containing compound probiotic ingredient
Toungos Lemongrass (Cymbopogon, L. Spreng) valuable grass but underutilized in Northern Nigeria
David Preparation of herbal shrikhand prepared with basil (Ocimum basilicum) extract
KR100879016B1 (en) Method for manufacturing herbal improved soy sauce and herbal improved soy sauce composition prepared by the method
CA2392728A1 (en) Aqueous disinfectant/sterilizing agent for foods
KR101148006B1 (en) Manufacturing Process of Ginseng Chicken Broth Including Trepang and Ginseng Chicken Broth Manufactured thereby
JP2009195217A (en) Lonicera caerulea l. product containing acid liquid usable also for salt repelling person and with good keeping quality
CN107373283A (en) Bean product preservative and preparation method thereof
KR20070024686A (en) Herb Nurungji Chicken White Soup
KR100785974B1 (en) Body composition suppressing cosmetic composition
KR101491732B1 (en) ripe persimmon ice cream Manufacturing methods using Composition of ice cream using ripe persimmon
KR100893384B1 (en) Onion Kimchi Onion Cultivation Method
KR20090022208A (en) Sweet and sour collagen garlic leaching tea composition and its manufacturing method
KR101128017B1 (en) Method for growing onion using seawater
CN1718035A (en) Cypress leaf tea processing method
JP2020043851A (en) Natural beverage composition containing caffeine and phosphate-free Arqiat extract
Branson 101 Amazing Uses for Apple Cider Vinegar: Soothe an Upset Stomach, Get More Energy, Wash Out Cat Urine and 98 More!
Smith Wonders in weeds
KR20120109675A (en) The method for manufacturing of health drink
KR101253096B1 (en) Composition Collagen ＆ Yacon With Sweet ＆ Palatability Dry Laver

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination